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Abstract
Proper cell-cell and cell-extracellular matrix (ECM) interactions are vital for cell
migration and patterning of the vertebrate embryo. Matrix metalloproteinases (MMPs) and
their inhibitors, reversion-inducing cysteine-rich proteins with Kazal motifs (RECK) and
tissue inhibitors of metalloproteinases (TIMPs), are all differentially expressed during
embryogenesis to regulate such ECM remodeling events and cell interactions. While TIMPs
are a family of 4 secreted proteins that share overlapping substrate specificities of MMPs,
RECK is unique in that it is a membrane-anchored MMP inhibitor that is embryonic lethal in
mice. I used Xenopus laevis as a model organism to investigate the role of RECK as a
regulator of ECM turnover during development. The X. laevis RECK sequence was
compared to a breadth of vertebrate and a few invertebrate RECK amino acid sequences. The
X. laevis RECK amino acid sequence was found to be highly conserved with other RECK
proteins. RECK knockdown in X. laevis embryos resulted in neural tube closure failure and
axial defects, in part due to altered mRNA levels of MT1-MMP, MMP-2, and TIMP-2. Upon
examination of RECK, MT1-MMP, and TIMP-2 protein localization in different tissues
throughout early X. laevis development, I found that all 3 proteins showed highly similar
localization patterns, particularly in the dorsal-ventral differentiation of the neural tube. To
further investigate RECK regulation of MMP activity in vitro, I used X. laevis A6 cells to
knockdown, overexpress, and shed RECK from the cell surface. I demonstrated that changes
in RECK levels (overexpression and cell surface shedding) that may reduce the ability of the
cell to remodel the ECM are compensated for by increases in MT1-MMP and MMP-2 levels
and changes in ERK signaling. Altogether, these results support a role for RECK in the
regulation of ECM remodeling and tissue patterning during X. laevis development.
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Summary for Lay Audience
All cells secrete or release materials around themselves, allowing tissues to form. In
multicellular organisms such as ourselves, some of these materials form a network (the
extracellular matrix or ECM) in which the cells anchor themselves to. In adults, the ECM
provides stability and a safe environment in which our cells can carry out their functions muscle cells contract, nerve cells communicate, and so on. But the situation is different in a
developing embryo. As animals grow from a fertilized egg, cells need to move. In adults,
when cells move, it is often associated with a disease state, such as cancer cells
metastasizing. Thus, understanding how cell movement is regulated is essential to both
embryogenesis and adults. For cells to move around, the ECM network that surrounds them
often has to be broken down and then remade. The molecules involved in this breakdown are
called matrix metalloproteinases (MMPs), and one of their roles is to cleave the ECM. Their
activity has to be tightly regulated as excessive ECM degradation is detrimental. Therefore,
there are 2 other molecules, tissue inhibitors of metalloproteinases (TIMPs) and reversioninducing cysteine-rich protein with Kazal motifs (RECK), whose roles are to control MMPs.
RECK is a protein found on the surface of cells and stops cells from moving by preventing
MMPs from cleaving components of the ECM. RECK has been identified as a crucial player
during embryogenesis, though exactly why RECK is essential to development remains
unclear. My research examined the role of RECK during frog development. I found that
reducing RECK levels in frog embryos caused abnormal development, particularly in the
formation of the spinal cord. These defects were in part due to improper ECM degradation.
Additionally, I found that RECK is associated with MMPs even after cells migrate, at a time
when embryonic cells are beginning to specialize, particularly into nerve cells. Thus, in
addition to regulating MMPs when cells are migrating, RECK also plays a role after ECM
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breakdown to signal to and help cells function. Overall, my study supports the role for RECK
as an important regulator of cell movement during embryogenesis.
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Chapter 1
1

Global Introduction and Literature Review

Portions of this chapter have been published as a review article: “Willson, J.A. and
Damjanovski, S. (2014). Vertebrate RECK in development and disease. Trends in Cell
and Molecular Biology, 9: 95-105”. (Reprint permission in Appendix A). The text has
been modified from the original manuscript to adhere to formatting guidelines for this
thesis. J.A.W. wrote the manuscript and S.D. edited the manuscript.
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1.1 The Extracellular Matrix
The extracellular matrix (ECM) is the non-cellular network of interacting
macromolecules that surrounds cells in metazoans. It is primarily composed of
proteoglycans, which are large hydrophilic molecules, and large fibrous proteins, such as
collagens and fibronectin, that provide structural support to cells. These fibrous proteins
may contain important signaling domains, such as the epidermal growth factor (EGF)
domain of laminin and heparin-II domain of fibronectin, which influence cell behaviour
(Daley et al., 2008). There are 2 main types of ECM in animal tissues: basement
membrane and interstitial matrix. The basement membrane is a thin layer of defined
ECM that underlies epithelial cells, providing a barrier between epithelia and
mesenchyme, whereas the interstitial matrix is a vast network of ECM surrounding
sparsely packed cells that make up connective tissue, such as cartilage and bone (McKee
et al., 2019). The amount and composition of ECM is specific to each type of tissue and
is crucial for the overall integrity and function of that tissue.
The ECM not only provides a scaffolding network for cells, but it also sequesters
a variety of signaling molecules including cytokines and growth factors, that once
released, regulate cell growth, survival, migration, and differentiation (Daley et al.,
2008). Changes in cell-cell and cell-ECM contact and the release of these sequestered
proteins occur through cleavage and remodeling of the ECM, and as such, these
processes are crucial for proper development and maintenance of multicellular organisms
(Daley et al., 2008). The integrity and breakdown of the ECM is regulated mainly
through the combined action of a group of extracellular proteases called matrix
metalloproteinases (MMPs).
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1.2 Matrix Metalloproteinases
There are 24 vertebrate MMPs, each with their own, but overlapping, ECM
substrate specificities. MMPs are present in all metazoans and their expression is crucial
in guiding many embryonic cell signaling and migration events (Visse and Nagase,
2003). MMPs are classified into 2 categories based on their localization and structure:
secreted MMPs, which are soluble in the ECM, and membrane type (MT)-MMPs, which
are tethered to the cell membrane. The 3 common domains of MMPs are an N-terminal
signal sequence that targets them for secretion, a pro-domain that inhibits catalytic
activity, and a catalytic domain with endopeptidase activity (summarized in Fig. 1.1). All
MMPs are synthesized as inactive zymogens and become activated with the removal of
their pro-domain. MT-MMPs reach the cell surface in an active form, as they have their
pro-domain cleaved intracellularly in the Golgi by furin-like proteases, whereas secreted
MMPs are activated in the ECM by other active MMPs already present (Sternlicht and
Werb, 2001). Once active, the common, but not only function of all MMPs, is to cleave
and remodel the ECM through selective degradation of ECM proteins (Vu and Werb,
2000).

1.2.1

MT1-MMP
A well-characterized member of the MMP family is MT1-MMP. Unlike secreted

MMPs, which can diffuse freely though the ECM, MT-MMPs are anchored to the cell
surface and their function is therefore restricted to the pericellular space (Seiki, 2002). Of
the many MMP null mice, only MT1-MMP null mice die shortly after birth due to severe
skeletal defects (Holmbeck et al., 1999). MT1-MMP can cleave major components of the
ECM, including collagen types I, II, and III, but it can also cleave non-ECM proteins,

4
Figure 1.1 MMP domain structure.
The various domains of human MMPs are shown. SP=signal peptide, Pro=pro-domain,
Cat=catalytic

domain,

F=fibronectin

II

repeats,

PEX=hemopexin

domain,

TM=transmembrane domain, C=cytoplasmic domain, GPI=Glycosylphosphatidylinositol
anchor, Cys=cysteine array, Ig=immunoglobulin-like domain. The flexible hinge region
is shown by the black zigzag line. (Modified from Radisky and Radisky, 2015).
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such as clusters of differentiation 44 (CD44) and activate pro-MMP-2 (Gifford and Itoh,
2019). These non-proteolytic functions may in fact help to explain its embryonic
necessity.
One of the confounding properties of MT1-MMP is its ability to cause an increase
in cell migration even when it is in a proteolytically inactive form (Bonnans et al., 2008;
Hara et al., 2011). These studies suggest that MT1-MMP may influence cell migration
beyond a role that relies solely on ECM degradation. In fact, recent studies have shed
light on a new mechanism of MT1-MMP involving extracellular signal-regulated (ERK)
activation (Cepeda et al., 2016; Cepeda et al., 2017; Takino et al., 2010; Willson et al.,
2018). The mitogen-activated protein kinase (MAPK)/ERK pathway is a signaling
cascade that is initiated by an extracellular mitogen, which subsequently leads to the
activation of ERK and the transcription of various genes involved in growth, survival,
differentiation, and development (Morrison, 2012). These multifunctional properties
reveal the importance of MT1-MMP in both cell-ECM interactions as well as cellular
behaviour.

1.2.2

The Gelatinases
The gelatinases, MMP-2 and MMP-9, have been identified as 2 potent secreted

proteases due to their ability to cleave gelatin, but more importantly collagen type IV, a
major component of basement membranes (Khasigov et al., 2003). Since cleavage of the
basement membrane is an important step during cell migration, MMP-2 and MMP-9 have
been implicated to play important roles during both development and cancer progression.
Although the severity of defects that arise from knocking out only one MMP gene may be
subdued due to functional redundancy between the different members of the MMP

7
family, defects have still been observed in single MMP knockout mice. For example,
MMP-2 null mice display craniofacial defects (Mosig et al., 2007), and MMP-9 null mice
exhibit defects in endochondral bone formation (Vu et al., 1998), both of which rely on
extensive ECM degradation and cell migration.
In adults, ECM remodeling is limited, and any disturbances in MMP levels can
contribute to the onset and progression of diseases (Visse and Nagase, 2003). While the
dysregulation of MMPs is associated with a number of disease states that involve cell
migration, including atherosclerosis (Lin et al., 2014), fibrosis (Giannandrea and Parks,
2014), and arthritis (Burrage et al., 2006), a major focus has been on their role in cancer,
particularly the importance of MMP-2 and MMP-9, whose upregulation have been
associated with tumour progression and metastasis (Bergers et al., 2000; Bernhard et al.,
1994; Jodele et al., 2005; Mook et al., 2004). Therefore, as it is crucial that MMP activity
be tightly regulated, there are a number of different endogenous inhibitors that control
MMP activity, including tissue inhibitors of metalloproteinases (TIMPs) (Visse and
Nagase, 2003).

1.3 Tissue Inhibitors of Metalloproteinases
TIMPs, endogenous inhibitors of MMPs, are a small family of secreted proteins.
All 4 TIMPs have been identified in mammals, but not all 4 are found in all vertebrates.
For example, only TIMP-1, TIMP-2, and TIMP-3 have been identified in frog.
Depending on the type, TIMPs are either expressed constitutively or in a tissue-specific
manner, and each are regulated at the transcriptional level through cytokine and growth
factor signaling (Murphy, 2011). For example, TIMP-2 is constitutively expressed,
whereas TIMP-3 is expressed predominantly in the central nervous system (Nuttall et al.,
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2004). Overall, each TIMP has overlapping abilities to inhibit members of the MMP
family. TIMPs contain structurally and functionally distinct N- and C-terminal domains.
The N-terminal domain binds to MMPs with a 1:1 molar stoichiometry and inhibits MMP
catalytic activity (Gomis-Ruth et al., 1997), whereas the C-terminal domain functions
independently by binding to cell surface receptors and inducing cell signaling cascades
(Visse and Nagase, 2003).
One of the best described non-MMP-inhibitory functions of TIMPs involves
TIMP-2. As previously mentioned in Section 1.2.1, an important function of MT1-MMP
is its ability to activate pro-MMP-2 (Itoh et al., 2001). The mechanism involves binding
of the C-terminal domain of TIMP-2 to the hemopexin-like domain of pro-MMP-2, while
the N-terminal domain of that same TIMP-2 molecule binds the catalytic site of
MT1-MMP and inhibits its proteolytic activity. This complex then allows an adjacent
active MT1-MMP molecule to cleave the pro-domain of MMP-2, which releases it from
the complex in an intermediate form. The intermediate form of MMP-2 then
autocatalyzes into its active form (Fig. 1.2) (Itoh et al., 2001). This ability of MT1-MMP
to activate MMP-2 and thus increase ECM remodeling therefore further potentiates cell
migration.
Due to their importance in mediating ECM turnover, the balance between MMPs
and TIMPs is crucial for proper development to occur. For example, overexpression of
TIMP-1, TIMP-2 or TIMP-3 during early Xenopus laevis development all resulted in
severe developmental defects (Nieuwesteeg et al., 2012; 2014). Until recently, TIMPs
were thought to be the main MMP inhibitors, however, another protein has been
discovered to play a role in mediating MMP activity. Reversion-inducing cysteine-rich
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Figure 1.2 Pro-MMP-2 activation.
The C-terminal domain of TIMP-2 binds to the hemopexin-like domain of pro-MMP-2,
while the N-terminal domain of TIMP-2 binds the catalytic site of a MT1-MMP. An
adjacent active MT1-MMP protein then cleaves the pro-domain of MMP-2, thus
releasing MMP-2 in its intermediate form. The intermediate form of MMP-2 then
undergoes autocatalytic cleavage to generate an active form of MMP-2. (Based on Itoh et
al., 2001).
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protein with Kazal motifs (RECK) encodes a membrane-anchored protein and regulates
ECM remodeling by inhibiting MMP activity (Takahashi et al., 1998).

1.4 RECK
1.4.1

Protein Structure
RECK was originally discovered by screening a human fibroblast cDNA library

for genes that induced flat cell morphology (reversion-inducing clones) when expressed
in transformed mouse fibroblasts (Takahashi et al., 1998). Mammalian RECK proteins
are 971 amino acids in length and weigh approximately 110 kDa (Takahashi et al., 1998).
Many vertebrate and invertebrate RECK sequences cloned to date are highly conserved at
the amino acid level and share the domains characteristic of RECK (Willson and
Damjanovski, 2014). RECK proteins contain hydrophobic regions flanking both ends of
the protein. The N-terminal region encodes a signal peptide sequence and the C-terminal
region encodes a glycosylphosphatidylinositol (GPI)-anchoring signal sequence (Fig. 1.3)
(Takahashi et al., 1998). RECK was confirmed as a GPI-anchored protein by treatment
with phospholipase C, an enzyme that selectively cleaves GPI-anchored proteins from the
surface of cells (Takahashi et al., 1998). RECK proteins are also rich in cysteine residues
(9%) and contain 5 repeats of a putative cysteine knot motif located near their N-terminus
(Fig. 1.3) (Takahashi et al., 1998).
As the name suggests, RECK proteins contain Kazal motifs, which are
serine-protease inhibitor-like domains (Fig. 1.3) (Rimphanitchayakit and Tassanakajon,
2010). There are 3 Kazal motif domains in RECK proteins. Evidence shows that these
Kazal motifs play an important role in MMP inhibition (Chang et al., 2008). The middle
portion of RECK proteins also contains 2 partial EGF-like repeats (Fig. 1.3) (Takahashi
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Figure 1.3 Domain organization of a typical RECK protein based on the 971 amino
acid human protein sequence.
Mammalian RECK proteins contain a signal sequence at the N-terminus and a GPI
anchor signal sequence at the C-terminus (which are not present in the mature protein).
The N-terminal region of RECK contains 5 putative cysteine knot motifs. The C-terminal
region contains 3 Kazal motifs (MMP inhibitory domains) and 2 epidermal growth
factor-like repeats. (Adapted from Takahashi et al., 1998).
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et al., 1998). EGF domains are common to membrane-bound and secreted proteins and
have the potential to bind to EGF receptors and stimulate mitosis (Wouters et al., 2005).

1.4.2

Tumour Suppression
Since its discovery in transformed fibroblasts, RECK quickly became recognized

as a tumour suppressor protein, and studies were carried out to determine if there was a
correlation between RECK expression and tumour cell invasiveness. In normal adult
tissues, RECK mRNA is relatively highly expressed, however, RECK expression is low
and sometimes undetectable in many tumour-derived cell lines (Takahashi et al., 1998).
Takahashi et al. (1998) was the first to determine the anti-invasive properties of RECK
by generating stable RECK-expressing fibrosarcoma cells and showing that invasiveness
significantly decreased in RECK-expressing cells versus control. Soon after, various
human tumours were analyzed to determine the relationship between RECK expression
and prognosis, including breast (Span et al., 2003), lung (Takenaka et al., 2005),
pancreatic (Masui et al., 2003), colorectal (Takeuchi et al., 2004), and prostate (Ohl et al.,
2005) cancer. These studies concluded that high RECK expression in tumours correlated
with better prognosis and survival rate.
Given that loss of RECK is associated with tumour progression, Walsh et al.
(2015) examined if loss of RECK is sufficient to transform normal cells. They knocked
down RECK in normal human mammary epithelial cells and examined cell
transformation using xenograft assays. RECK knockdown was not sufficient to induce
transformation (Walsh et al., 2015). Therefore, although reconstitution of RECK in
transformed cells reduces invasiveness, loss of RECK does not lead to malignant
transformation.
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1.4.3

MMP Inhibition
RECK was originally identified as a tumour suppressor due to its ability to

regulate MMP activity (Takahashi et al., 1998). Numerous in vitro studies have shown
that RECK can negatively regulate MMP-2, MMP-9, and MT1-MMP activity (Fig. 1.4)
(Chang et al., 2008; Matsuzaki et al., 2018; Oh et al., 2001; Simizu et al., 2005;
Takahashi et al., 1998). The pioneering study was conducted by Takahashi et al. (1998)
who saw a decrease in the amount of pro-MMP-9 in serum collected from fibrosarcoma
cells transfected with RECK. This result only occurred when RECK was membranebound. When RECK was solubilized, pro-MMP-9 levels in the serum did not change
(Takahashi et al., 1998). Oh et al. (2001) expanded on these results and reported that
levels of active MMP-2 also decreased in RECK-expressing fibrosarcoma cells. They also
showed that RECK can directly interact with MT1-MMP and inhibit its proteolytic
activity.
Since RECK proteins contain Kazal motifs, which are protease-inhibitor domains,
it is no surprise that evidence suggests these domains play a role in MMP inhibition.
Chang et al. (2008) generated recombinant proteins containing all 3 Kazal motifs (K123)
or only the last 2 Kazal motifs (K23). Using human lung cancer cells, they showed that
K23 recombinant proteins reduced pro-MMP-9 and active MMP-2 and MMP-9 levels.
Moreover, K23 recombinant proteins bound directly to MMP-9. Surprisingly, K123 did
not show any MMP inhibition, however, they attributed this result to protein misfolding
(Chang et al., 2008). Their results also showed that RECK does not need to be
membrane-bound in order for inhibition of pro-MMP-9 to occur (Chang et al., 2008),
which is contrary to earlier studies that claimed they did not see a reduction in
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Figure 1.4 Role of RECK as an MMP inhibitor.
RECK is a membrane-anchored protein and has been shown to directly inhibit
MT1-MMP, MMP-2, and MMP-9 activity. RECK can also inhibit the secretion of
pro-MMP-9, although the mechanism is unknown. RECK has also been shown to inhibit
MMP-9 transcription by preventing Fra-1 and c-Jun from binding to the TRE-1 binding
site on the MMP-9 promoter region, leading to less secreted pro-MMP-9. (Based on
Chang et al., 2008; Oh et al., 2001; Takagi et al., 2009; Takahashi et al., 1998).
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pro-MMP-9 levels using solubilized RECK proteins (Takahashi et al., 1998).
An important factor in the progression of tumour growth and metastasis is the
branching of new vascular networks from pre-existing ones, termed angiogenesis
(Hoeben et al., 2004). With respect to tumour progression, not only does RECK decrease
invasiveness, but RECK has also been shown to suppress tumour angiogenesis. When
RECK-expressing tumour cells were inoculated into mice, RECK+-tumoured mice lived
longer and displayed a reduction in angiogenic sprouting, as was seen by laminin staining
versus the mice inoculated with control tumours (Oh et al., 2001).
As a GPI-anchored protein, RECK does not contain an intracellular domain,
however, many GPI-anchored proteins are involved in transducing cell-signaling
cascades by binding to neighboring receptors (Mayor and Riezman, 2004). Takagi et al.
(2009) were the first to discover that RECK decreases MMP-9 transcription.
Overexpression of RECK in fibrosarcoma cells caused a decrease in MMP-9 mRNA, but
not MMP-2 mRNA. Although they also saw a decrease in the amount of MMP-9 present
in the serum from RECK-expressing fibrosarcoma cells, they attributed this result to the
decrease in MMP-9 mRNA, not inhibition of pro-MMP-9 secretion. They discovered that
RECK overexpression suppressed the binding of Fos-related antigen 1 (Fra-1) and c-Jun
transcription factors to the 12-O-tetradecanoylphorbol-13-acetate-responsive element-1
(TRE-1) binding site within the MMP-9 promoter region in fibrosarcoma cells. However,
the mechanisms underlying this process are currently unknown. For example, there is no
evidence to suggest that RECK translocates to the nucleus. Instead, RECK may act on the
surface of cells by interacting with other cell surface receptors (Takagi et al., 2009).
In fact, a study has suggested that RECK may not only bind to MT1-MMP to
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inhibit its catalytic activity, but it may also modulate the endocytic pathway of
MT1-MMP. A study performed by Miki et al. (2007) examined whether RECK
influences the clearance of MT1-MMP and CD13, another membrane protease, from the
cell surface. They found that when RECK was present, it complexed with MT1-MMP
and CD13 and caused preferential endocytosis of these proteins using a novel endocytic
pathway that was caveolae-independent. This study highlights the multifaceted properties
of RECK as a cell surface protein.

1.5 Regulation of RECK
1.5.1

Oncogenic Signaling Represses RECK Expression
The MAPK/ERK pathway plays a crucial role in cell proliferation and

differentiation, however, aberrant activity of this pathway can lead to malignant
transformation (Kohno and Pouyssegur, 2006). For example, activated RAS causes a
decrease in ECM proteins and receptors and an increase in MMPs, such as MT1-MMP
(Howard et al., 1978; Plantefaber and Hynes, 1989; Thant et al., 1997). RECK was
discovered as a downstream target of oncogenic signaling, as reconstitution of RECK in
ras-transformed fibroblasts induced reversion (Takahashi et al., 1998). As such, studies
have been carried out to determine how RECK is regulated at the transcriptional level by
the MAPK/ERK pathway. There is a specificity protein 1 (Sp1)-binding site within the
RECK promoter region that has been identified as a repressor of RECK transcription
(Sasahara et al., 1999). Activation of ERK causes phosphorylation of Sp1, which is then
recruited to the Sp1 binding site along with histone deacetylase 1 (HDAC) and results in
repression of RECK transcription (Chang et al., 2004).
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1.5.2

TIMP-2 Induces RECK Expression
TIMPs are multi-faceted proteins. Not only do TIMPs inhibit MMPs, but they can

also bind to cell surface receptors and induce cell-signaling cascades (Li et al., 1999; Oh
et al., 2004). Of importance is the upregulation of RECK expression by TIMP-2. TIMP-2
was shown to bind to α3β1 integrins on the surface of human endothelial cells, causing
inactivation of proto-oncogene tyrosine-protein kinase (Src) through changes in paxillin
phosphorylation (Oh et al., 2004). Alteration of paxillin phosphorylation regulates the
activation of the small GTPase Ras-related protein 1 (Rap1), which ultimately results in
increased expression of RECK through unknown mechanisms (Oh et al., 2004).

1.5.3

Glycosylation of RECK
RECK has also been shown to be regulated at the post-translational level. RECK

contains 5 putative glycosylation sites at the N-terminal portion of the protein (Takahashi
et al., 1998). Glycosylation of 3 of the 5 potential asparagines of RECK are required to
suppress tumour cell invasion (Simizu et al., 2005). Simizu et al. (2005) generated RECK
mutants where they replaced asparagines with glutamines. RECK mutant constructs were
transfected into fibrosarcoma cells to measure the amount of MMP-2 and MMP-9 levels
in the media. Glycosylation of Asn297 was required to inhibit MMP-9 secretion and
Asn352 was required to inhibit the activation of pro-MMP-2. They also correlated
glycosylation of RECK with tumour cell invasion and found that glycosylated Asn86,
Asn297, and Asn352 residues were required to suppress fibrosarcoma cell invasion (Simizu
et al., 2005).

1.6 RECK in Development
During embryonic development the ECM undergoes extensive remodeling. As
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such, MMPs are expressed, and studies have found that aberrant upregulation of MMPs
has been associated with developmental defects and death (Page-McCaw et al., 2007).
Therefore, to maintain an appropriate level of MMP activity, MMP inhibitors are also
crucial for proper development to occur. Although TIMP-1 or TIMP-2 deficiency in
mouse embryos has little effect on development (Caterina et al., 2000; Nothnick et al.,
1997), most likely due to functional redundancy between TIMPs, RECK is necessary for
mouse development. Oh et al. (2001) were the first to report that RECK knockout in mice
resulted in embryonic lethality.

1.6.1

Angiogenesis
When the RECK gene was knocked out in mice, about 2/3 of RECK-/- embryos

died halfway through embryogenesis at embryonic day (ED) 10.5, and none survived past
ED11.5 (Oh et al., 2001). RECK-/- embryos had overt phenotypes, which included
abdominal hemorrhaging, disorganized vascularization, disrupted organogenesis, and
smaller body sizes (Oh et al., 2001). Although vascular networks were present in RECK-/embryos, histological examination of these tissues indicated abnormally large and
deformed blood vessels, which indicated defects in angiogenesis rather than
vasculogenesis (Oh et al., 2001).
Due to its characterized role in MMP inhibition, RECK-/- mice were analyzed to
determine if there was aberrant upregulation of MMPs in vivo. Oh et al. (2001) plated
ED10.5 cells and collected the serum. MMP-2 activity was elevated in RECK-/- embryos,
however, since pro-MMP-9 is not expressed until ED11, MMP-9 activity was not
detected (Oh et al., 2001). Collagen IV and laminin were also disrupted in areas
surrounding blood vessels and the neural tube in RECK-/- embryos (Oh et al., 2001).
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These results suggest that loss of RECK caused aberrant upregulation of MMPs and
disruption of the basal lamina. This is supported by the fact that RECK, MMP-2, and
MT1-MMP expression patterns overlap in the areas surrounding the neural tube.
Furthermore, a similar phenotype was seen in collagen 1-/- mice, which also died due to
ruptured blood vessels (Löhler et al., 1984). A partial rescue of the RECK mutant
phenotype was obtained by generating RECK-/-/MMP-2-/- double mutants. These embryos
had larger body sizes and improved vascular integrity, however, they still died half a day
later (ED11.5) (Oh et al., 2001). On the other hand, RECK-/-/MT1-MMP-/- mutants did not
rescue the RECK mutant phenotype (Oh et al., 2001).
Chandana et al. (2010) tried a conditional RECK knockout by silencing the RECK
gene using tamoxifen-inducible treatment at ED11, however, mice still showed lethality.
Conditional RECK-/- mutants had large and deformed blood vessels as well as large
cavities in the brain vasculature at ED15.5 (Chandana et al., 2010). This phenotype was
also apparent when Prendergast et al. (2012) knocked down RECK in zebrafish using
Morpholinos (MO). RECK knockdown embryos had impaired vascular integrity and
intracranial hemorrhaging 48 hours post-fertilization (Prendergast et al., 2012). This
suggests that RECK function is conserved throughout development and essential
particularly with respect to vascular development.
Since RECK was implicated to play a role in angiogenesis during development,
Chandana et al. (2010) decided to examine the importance of RECK in maternal vascular
remodeling in mice. The uterus of a pregnant mouse is one of the most active sites of
angiogenesis in adult mice (Abrahamsohn and Zorn, 1993; Cross et al., 1994; Dey et al.,
2004). MMP-2 and MMP-9 expression patterns are very dynamic during vascular
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remodeling in the uterus and are required for proper ECM remodeling (Curry and Osteen,
2003; Wang and Dey, 2006). However, it is unclear how some blood vessels are
protected while others undergo extensive vascular sprouting. RECK was implicated to
play a role in vascular remodeling in maternal tissues. RECK is expressed in cells
associated with remodeling blood vessels in the mouse implantation chamber (Chandana
et al., 2010). When they knocked down RECK expression within the implantation
chamber using short hairpin RNA (shRNA), cavities and tissue slits were present instead
of organized and compact blood vessels (Chandana et al., 2010). They also saw decreased
collagen IV surrounding the deformed blood vessels (Chandana et al., 2010). This
phenotype is very similar to the vascular defects seen in RECK-/- embryos and supports
the role of RECK as a key regulator during angiogenic sprouting (Chandana et al., 2010).
Mechanisms of RECK action during angiogenesis have been proposed by Chandana et al.
(2010). The most likely scenario suggests that RECK helps mark and protect the blood
vessels that are preserved during angiogenic sprouting by inhibiting surrounding MMPs.
However, RECK-/- embryos cannot be rescued by MMP null mutations, although this may
be due to functional redundancy between MMPs. Instead, RECK may affect intracellular
signaling pathways by protecting ECM proteins and other cell surface receptors
(Chandana et al., 2010). Angiogenesis occurs when vascular endothelial growth factor
(VEGF) and Notch signaling regulate endothelial tip cell formation (Adams and Alitalo,
2007; Carmeliet, 2005; Roca and Adams, 2007). Delta-like 4 (Dll4), a ligand of Notch
signaling, has been reported to reduce tip cell formation and thus vascular sprouting
(Phng and Gerhardt, 2009). Interestingly, the vascular defects seen in RECK-/- embryos
are very similar to the phenotype that occurs in mouse embryos with attenuated Notch
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signaling (Krebs et al., 2000; Xue et al., 1999). RECK has been shown to activate Notch
signaling during cortical neurogenesis by protecting Dll4 from being shed from the
membrane (Muraguchi et al., 2007). Therefore, RECK deficiency may suppress Notch
signaling during embryonic and maternal angiogenesis and cause excessive sprouting
(Fig. 1.5). However, this mechanism of action does not solely explain the large cavities
formed in RECK-deficient tissues. The biggest unanswered question that remains is why
RECK is necessary for embryonic angiogenesis but suppresses tumour angiogenesis.
Although it was recently discovered that RECK suppresses angiogenesis by
downregulating signal transducer and activator of transcription 3 (STAT3) (Walsh et al.,
2015), no link has been made to whether or not this process occurs during developmental
angiogenesis.

1.6.2

Neurogenesis

Notch signaling is a highly conserved pathway that is crucial during development to
ensure cell fate specification, stem cell maintenance, and tissue patterning (Roca and
Adams, 2007). In the mammalian central nervous system, Notch ligands, Dll and Jagged,
are expressed on the surface of neural cells and bind to Notch present on the surface of
neighboring neural precursor cells (Roca and Adams, 2007). Once activated, Notch
signaling maintains neural precursor cells in an undifferentiated state (Roca and Adams,
2007). Notch signaling is regulated by a disintegrin and metalloproteinase-10
(ADAM-10) (Yang et al., 2006). ADAM-10 proteases are expressed throughout
development in various neural cells in the mammalian central nervous system and inhibit
Notch signaling by cleaving Notch ligands from the surface of neural cells to allow
differentiation (Kärkkäinen et al., 2000; LaVoie and Selkoe, 2003; Mishra-Gorur et al.,
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Figure 1.5 Role of RECK in vascular sprouting.
During vascular sprouting in tip cells, VEGF and Notch signaling modulate the selective
formation of tip cells. VEGF signaling in tip cells leads to high levels of Dll4. Dll4 binds
to Notch on neighboring stalk cells, which induces Notch signaling and attenuates
VEGFR signaling. RECK has been proposed to regulate vascular sprouting by
maintaining Notch signaling, however the mechanism is currently unknown. (Based on
Muraguchi et al., 2007).
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2002).
RECK-/- mice embryos not only had vascular defects, but they also had premature
differentiation of neural precursor cells (Muraguchi et al., 2007). This phenotype was a
result of impaired Notch signaling in the central nervous system (Muraguchi et al., 2007).
They demonstrated that RECK regulated Notch signaling by directly inhibiting
ADAM-10 in neural precursor cells. They confirmed this by showing a direct interaction
between

RECK

and

ADAM-10

by

co-immunoprecipitation

as

well

as

by

co-electroporating shRNA targeting ADAM-10 and RECK in the central nervous system
of ED12.5 wildtype embryos and rescuing the phenotype induced by RECK depletion
(Muraguchi et al., 2007).
A more recent study expanded on these results and reported that RECK was
regulated within this pathway by glycerophosphodiester phosphodiesterase 2 (GDE2)
(Park et al., 2013). GDE2 is a 6-transmembrane protein that is crucial for the
differentiation of spinal motor neurons by inhibiting Notch signaling (Rao and
Sockanathan, 2005; Sabharwal et al., 2011; Yan et al., 2009). Interestingly, GDE2 and
RECK mRNA expression colocalize in differentiating motor neurons during neurogenesis
in chicks (Park et al., 2013). Using chick spinal cord extracts, they determined that GDE2
cleaves RECK within the GPI-anchor. The release of RECK prevents inhibition of
ADAM-10, which then sheds Dll from the surface and attenuates Notch signaling
(Fig. 1.6) (Park et al., 2013).

1.6.3

Neural Crest Cell Migration
Neural crest cells are a transient population of migratory cells that differentiate

into a variety of cell types within the vertebrate embryo, including melanocytes, smooth
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Figure 1.6 Role of RECK in neurogenesis.
RECK maintains Notch signaling in neural progenitor cells by inhibiting the proteolytic
activity of ADAM-10 on the surface of neural cells. ADAM-10 sheds Notch ligands from
the surface, preventing the intracellular domain (ICD) of Notch to translocate to the
nucleus and turn on target genes that maintain neural progenitor cells. The presence of
RECK prevents shedding of Notch ligands and maintains Notch signaling. In addition,
GDE2 regulates RECK by cleaving its GPI-anchor. This prevents inhibition of
ADAM-10 and thus attenuates Notch signaling. (Based on Muraguchi et al., 2007; Park
et al., 2013; Yang et al., 2006).
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muscle, sensory ganglia, and craniofacial cartilage and bone (Le Douarin and Kalcheim,
1999). RECK knockdown in zebrafish embryos was also reported to have defects in
neural crest migration (Prendergast et al., 2012). Prendergast et al. (2012) began their
study by screening zebrafish mutants that were unable to form the dorsal root ganglia
(DRG) by looking at neurogenin expression and found that this phenotype was a result of
a mutation in the RECK gene. In the absence of RECK, neural crest cells exhibited
aberrant migratory behaviour and were unable to migrate to the appropriate position for
differentiation into DRG. They confirmed this phenotype by also knocking down RECK
expression using MOs (Prendergast et al., 2012). RECK mutants displayed increased
MMP activity, as shown by taking protein extracts from embryos and incubating them
with dye-quenched (DQ) gelatin, a substrate that allows for quantification of MMP
activity (Prendergast et al., 2012). However, this phenotype could not be rescued by the
treatment of MMP inhibitors (Prendergast et al., 2012). This study was also the first to
determine that RECK function is cell autonomous. Cells taken from wildtype embryos
and transplanted into RECK knockdown embryos were able to form DRG, but they
couldn’t induce the host cells (RECK knockdown cells) to form DRG (Prendergast et al.,
2012).

1.6.4

Limb Patterning
When the RECK gene was knocked out in mice, embryos did not survive past

ED11 (Oh et al., 2001). Therefore, although studies have focused on the role of RECK
early on during development, little is understood regarding developmental processes
occurring later in embryogenesis. Therefore, Yamamoto et al. (2012) generated
low-RECK mutants, which have reduced RECK expression, to examine later stages of
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development. The most obvious phenotype displayed in these mutants was limb
abnormalities. Further histological examination showed poor chondrocyte condensation
in forelimb buds (Yamamoto et al., 2012). To determine potential morphogenetic
signaling molecules affected by low RECK expression in mice such as Wnt7a signaling
and sonic hedgehog (Shh) signaling, in situ hybridization was performed. These signaling
pathways were all attenuated in low-RECK mutants (Yamamoto et al., 2012).
Interestingly, Wnt7a-/- embryos displayed very similar limb abnormality phenotypes,
whereas deficiencies in the other signaling pathways (such as Shh or bone morphogenetic
protein (BMP)) yielded distinctly different phenotypes (Adamska et al., 2004; Chiang et
al., 1996; Selever et al., 2004). Indeed, Wnt7a expression was greatly reduced in
low-RECK mutant forelimb buds. They came to the conclusion that RECK is required for
Wnt7a signaling in the forelimb bud (Yamamoto et al., 2012).

1.7 The X. laevis System
The African clawed frog, X. laevis, has been widely used in the developmental biology
field since the 1950s (Schmitt et al., 2014). The X. laevis system provides a number of
advantages as a model organism, including the ease of in vitro fertilization and rearing as
well as their resilience to experimental manipulation. Moreover, development occurs
rapidly, and each stage has been well-characterized (Nieuwkoop and Faber, 1956).
X. laevis embryos are large (approximately 1 mm in diameter) and therefore
developmental stages are easily recognizable (Fig. 1.7). Development begins at
fertilization (stage 1), followed by the blastula stage (stage 9), at which time zygotic
transcription is turned on. Within the first 24 hours post fertilization, gastrulation occurs
(stage 10-12), in which the 3 germ layers are formed (ectoderm, mesoderm, and
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Figure 1.7 Schematic representation of X. laevis developmental stages.
(a) Development begins with a fertilized single cell egg. Stage 9 (blastula stage) marks
the onset of zygotic transcription. Gastrulation occurs between stages 10 and 12 to form
the 3 germ layers (ectoderm, mesoderm, and ectoderm) and the embryonic axes.
Neurulation occurs between stages 14 and 20 to form the neural tube. Organogenesis and
differentiation are predominant in the tailbud stages (stages 21-28) and beyond. By stage
37 the embryo has hatched, and by stage 41 embryos have developed into feeding
tadpoles. (b) Schematic representation of an early tailbud embryo to denote the
embryonic axes. Dorsal refers to back and ventral refers to front (belly). Anterior refers to
head and posterior refers to tail. (Adapted from Nieuwkoop and Faber, 1956).
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endoderm) as well as the embryonic axes, followed by neurulation, which occurs between
stages 14 and 20 to form the neural tube (neural crest cell migration begins during these
stages as well). Organogenesis and differentiation begin at the tailbud stages, and by 3
days post fertilization (dpf), a functional free-swimming tadpole has developed (Fig. 1.7).
Thus, X. laevis has been a fundamental tool in studying cell cycle, cell metabolism, cell
behaviour, and cell migration during development (Hardwick and Philpott, 2015).
For a long time, investigators have taken advantage of the parallels that exist
between embryonic development and cancer metastasis. Many signaling pathways that
are crucial for normal development, such as BMP, Shh, and Notch pathways, become
unregulated during cancer metastasis (Bailey et al., 2007). ECM remodeling is yet
another example of an event that is highly dynamic during both development and cancer
metastasis. Therefore, using X. laevis as a model organism to study ECM remodeling
during development can assist in understanding why this process becomes uncontrolled
during tumour progression.
In vitro cell culture work can also be conducted using A6 cells, a well-established
cell line derived from X. laevis kidney tissue. These cells behave like typical polarized
epithelial cells and can be instrumental in studying cell signaling pathways and cell
behaviour in vitro (Mimori-Kiyosue et al., 2007), pathways which can be difficult to
discern in a multicellular embryo.

1.8 Research Project
1.8.1

Summary
ECM remodeling is a highly dynamic process that is important for the

development and maintenance of multicellular organisms. ECM degradation occurs
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primarily through MMPs, and their activity is modulated by their endogenous inhibitors,
TIMPs and RECK. Numerous studies have shown that perturbing the delicate balance
that exists between MMPs and their inhibitors can lead to devastating consequences to
the integrity and function of tissues. For example, uncontrolled ECM remodeling can
contribute to the onset and progression of cancer metastasis. For these reasons, it is
essential to understand the functions and interplay of these proteins and how they control
ECM remodeling to ensure proper development and tissue homeostasis.
The importance of RECK during development is becoming more evident, as
studies have already identified a role for RECK during angiogenesis, neural crest cell
migration, and limb patterning. Not only does RECK inhibit MMP function at many
levels, there is also emerging evidence suggesting that RECK may play a more important
role in regulating intracellular signaling. However, most research characterizing RECK
function has been done in vitro in tumour-derived cell lines. My research focused on the
functional characterization of RECK during X. laevis development, a well-established
developmental model. By disrupting endogenous RECK levels, I attempted to elucidate
the molecular mechanisms that are critical for balancing the proteolytic activity of MMPs
with the role of RECK required for proper ECM remodeling and tissue patterning during
development.

1.8.2

Hypotheses

1) Previous studies have revealed similar biological functions of RECK in
vertebrates, therefore, I hypothesize that all domains of vertebrate RECK peptide
sequences will share high evolutionary conservation.
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2) Since RECK transcripts are localized to dorsal axial structures in X. laevis
embryos, I hypothesize that alteration of RECK levels will cause axial and neural
tube defects in X. laevis embryos resulting from excessive ECM remodeling.
3) Previous studies have demonstrated that RECK is an inhibitor of MT1-MMP,
therefore, I hypothesize that X. laevis RECK will colocalize with MT1-MMP in
dorsal axial structures, including the neural tube and head region.
4) Given that RECK has an established role as an MMP inhibitor, I hypothesize that
knockdown/shedding of RECK in X. laevis A6 cells will result in increased
MT1-MMP and MMP-2 levels, whereas overexpression of RECK will result in
reduced MT1-MMP and MMP-2 levels.

1.8.3

Objectives
The overarching goal of this research was to characterize the role of X. laevis

RECK during development. I previously cloned the mature X. laevis RECK sequence,
which lacked the N-terminal signal sequence and C-terminal GPI-anchor signal sequence,
as part of my Master’s thesis, and performed a preliminary sequence comparison analysis
of RECK. However, that study was limited by the number of available annotated
sequences at the time. For this Doctoral study, I finished cloning the full-length X. laevis
RECK gene and performed a detailed sequence comparison of RECK with more diverse
species to determine evolutionary conservation. This research had the following
objectives:
1) To perform a comparison of amino acid sequence identity of X. laevis RECK to
other sequences to determine evolutionary conservation of domains (Chapter 2).
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2) To knock down RECK in X. laevis embryos using a MO approach. Following
RECK knockdown, to examine embryos for any subsequent morphological
changes and developmental defects and correlate these defects with alterations in
mRNA levels of developmental marker genes as well as ECM-remodeling genes
(Chapter 2).
3) To perform immunohistochemistry (IHC) on transverse sections of embryos to
determine the localization patterns of RECK, MT1-MMP, and TIMP-2 during
X. laevis neurulation and organogenesis (Chapter 3).
4) To disrupt endogenous levels of RECK in X. laevis A6 cells using a combination
of overexpression, knockdown, and phosphatidylinositol-specific phospholipase C
(PI-PLC) treatment experiments and examine the effects on MT1-MMP, MMP-2
and phosphorylated ERK (pERK) levels (Chapter 4).
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Chapter 2
2

Analysis of Xenopus laevis RECK and Its
Relationship to Other Vertebrate RECK Sequences

Data in this chapter have previously been published as: “Willson, J.A., Nieuwesteeg,
M.A., Cepeda, M., and Damjanovski, S (2015). Analysis of Xenopus laevis RECK and its
relationship to other vertebrate RECK sequences. Journal of Scientific Research and
Reports, 6(7): 504-513.” Copyright on any open access article in a journal published by
SCIENCEDOMAIN International is retained by me, the author, as per The Creative
Commons Attribution License 4.0. The text has been modified from the original
manuscript to adhere to formatting guidelines for this thesis. Figures 3 and 4 published in
that article (RT-PCR and in situ analysis of RECK) are not novel to this thesis as they
were included in my Master’s thesis, and thus have been excluded. The remaining
published figures 1, 2, and 5 are novel to this PhD thesis. The figures regarding RECK
MO knockdown in embryos are unpublished. Experiments were designed and carried out
by J.A.W., M.A.N. assisted with embryo rearing, M.C. edited the manuscript, and S.D.
provided funding, resources, and intellectual contributions.
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2.1 Introduction
During development the ECM undergoes extensive remodeling to allow needed
large-scale cell movements to occur. Degradation of the ECM occurs through a large
family of extracellular proteases called MMPs. Aberrant regulation of MMPs is
associated with developmental defects, and therefore, a delicate balance between the
levels of MMPs and their endogenous inhibitors is crucial for proper development.
RECK has recently been discovered to play a role in regulating MMP activity (Takahashi
et al., 1998).
The RECK gene encodes a GPI-anchored protein with 3 serine-protease
inhibitor-like domains (Kazal motifs) and 5 repeats of a putative cysteine knot motif. The
N-terminus contains a signal peptide sequence and the C-terminus contains a
GPI-anchoring signal sequence (Fig. 1.3) (Takahashi et al., 1998). All mammalian RECK
genes that have been sequenced to date are highly conserved at the amino acid level and
share the domains mentioned above. Mammalian RECK proteins are 971 amino acids in
length and mass of approximately 110 kDa (Takahashi et al., 1998). RECK has also been
sequenced from a variety of non-mammalian vertebrate and invertebrate species and has
been found to be evolutionarily conserved, however, X. laevis RECK has yet to be
characterized. Indeed, while numerous putative RECK genes can be predicted as many
organism genomes are being sequenced, proportionally reptile and amphibian (herptile)
RECK sequences are incomplete, of poor quality, or lacking in various phylogenic
databases.
RECK was first described as a tumour suppressor protein due to its anti-invasive
properties. Numerous in vitro studies showed that RECK can inhibit the proteolytic
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activity of 3 types of MMPs: MMP-2, MMP-9, and MT1-MMP (Oh et al., 2001; Takagi
et al., 2009; Takahashi et al., 1998). Since RECK functions by inhibiting MMPs, its
presence during development would suggest that it plays important embryonic roles as
well. Vertebrate RECK importance was demonstrated in knockout and knockdown
studies in mice and zebrafish, respectively. Oh et al. (2001) revealed that RECK-deficient
mice died halfway through embryogenesis with halted vascular development. In addition,
RECK knockdown in zebrafish resulted in impaired vascular integrity and lack of DRG
formation (Prendergast et al., 2012). RECK has also been shown to be important during
mouse secondary palate development (de Oliveira Demarchi et al., 2010) and mouse
forelimb development (Yamamoto et al., 2012). More recently RECK has also been
shown to modulate cell-migratory signaling pathways, independent of its MMP inhibitory
role (Chang et al., 2008; Walsh et al., 2015). As the developmental processes of neural
development and vascular branching both involve RECK and tightly controlled cell
migration and ECM remodeling events in mice and zebrafish, this implicates the
importance of RECK as a key embryonic regulator in other vertebrates.
While much in vitro analysis of RECK function is currently being carried out,
there is limited in vivo information regarding this protein, particularly in non-mammalian
vertebrates. In this chapter, I cloned and analyzed the sequence of X. laevis RECK and
examined its expression pattern during development. Expression analysis revealed that
X. laevis RECK expression is consistent with its vascular and nervous system roles seen
in mouse and zebrafish. I then used a MO approach to disrupt endogenous RECK levels
in X. laevis embryos. RECK knockdown led to severe neural tube closure defects, axial
defects, and reduced head structures. Additionally, polymerase chain reaction (PCR)
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analysis showed that RECK knockdown resulted in differential changes in MMP and
TIMP genes, suggesting that RECK is an important modulator of ECM remodeling
during X. laevis embryogenesis.

2.2 Materials and Methods
2.2.1

Animal Care and Rearing
Adult X. laevis were purchased from Xenopus 1, Inc (Dexter, MI). Animal rearing

and fertilizations were carried out as previously described (Sive et al., 2000). Developing
embryos were staged according to Nieuwkoop and Faber (1956) (Fig. 1.6). Animals were
housed and treated in accordance with UWO and CCAC guidelines.

2.2.2

Cloning X. laevis RECK
Since the X. laevis RECK sequence was not available online at the beginning of

this project, the Xenopus tropicalis database was used instead as the sequence of this
closely related species is better annotated. Based on the putative X. tropicalis RECK
sequence [XM_002938937.2], forward (5’-ATGTGTCGTGATGTATGTGA-3’) and
reverse (5’-TGGCGACAAAGAATACACCA-3’) primers were designed flanking the
predicted full-length coding region of the RECK gene. Total RNA was isolated from
adult X. laevis lung tissue using a RNeasy Kit (Qiagen) according to manufacturer’s
instructions. First-strand cDNA synthesis and PCR were performed on total RNA using
qScript Reverse Transcriptase (Quanta Biosciences) and Kapa Hi-Fi Taq PCR Kit (Kapa
Biosystems) according to manufacturer’s instructions.
The putative X. tropicalis RECK sequence [XM_002938937.2] was only partial
and lacked the signal peptide sequence at the 5’ end and the GPI-anchoring signal
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sequence at the 3’ end of the gene. Therefore, the nested gene specific primers for the 5’
end (outer: 5’-ATGTGTCGTGATGTATGTGAACAG-3’ and inner: 5’-CCTCCCTTAG
TTCAGTGTGT-3’) and 3’ end (outer: 5’-CCTGCAATTCCTGTCACAG-3’ and inner:
5’-CAACATGTCTCTGTACCTCAG-3’) were also generated to isolate the missing
domains of X. laevis RECK using the FirstChoice RNA Ligase Mediated Rapid
Amplification of cDNA Ends (RLM-RACE) Kit (Life Technologies) according to
manufacturer’s instructions. The amplicons were cloned into the pCR 4-TOPO vector
(Life Technologies) and sequenced at the DNA Sequencing Facility (Robarts Research,
London, ON, Canada). The final amplification of the full-length coding region of
X. laevis RECK was done using SuperTaq Plus (Life Technologies).

2.2.3

Sequence Analysis
The X. laevis RECK sequence obtained from PCR was translated using the

ExPASy

Bioinformatics

Resource

Portal

online

Translate

tool

(http://web.expasy.org/translate/). This X. laevis RECK sequence was submitted to
genbank as [AIZ00509.1]. Other well-annotated, full-length RECK protein sequences at
the time of publication along with the accession numbers used for comparison were from
the following species: human Homo sapiens [NP_066934.1], chimp Pan troglodytes
[XP_520575.2], rhesus monkey Macaca mulatta [XP_001083599.1], dog Canis lupus
familiaris [NP_001002985.1], cow Bos taurus [NP_001179394.1], mouse Mus musculus
[NP_057887.2], tiger Panthera tigris altaica [XP_007076663.1], alpaca Vicugna pacos
[XP_006204234.1], little brown bat Myotis lucifugus [XP_006102759.1], 13 lined
squirrel Ictidomys tridecemlineatus [XP_005326326.1], common shrew Sorex araneus
[XP_004600290.1], fresh water dolphin Lipotes vexillifer [XP_007456041.1], platypus
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Ornithorhynchus anatinus [XP_007661391.1], tasmanian devil Sarcophilus harrisii
[XP_003761399.1], chicken Gallus gallus [XP_418897.4], penguin Pygoscelis adeliae
[XP_009322770.1], bald eagle Haliaeetus leucocephalus [XP_010575445.1], ibis
Nipponia nippon [XP_009473764.1], hummingbird Calypte anna [XP_008500730.1],
pike Esox lucius [XP_010884005.1], croaker Larimichthys crocea [XP_010749852.1],
zebra

fish

Danio

rerio

[XP_009295477.1],

sole

Cynoglossus

semilaevis

[XP_008305649.1], alligator Alligator sinensis [XP_006019052.1], soft shell turtle
Pelodiscus sinensis [XP_006113101.1], frog X. tropicalis [XP_002938983.2], ghost
shark Callorhinchus milii [XP_007896317.1], coelacanth Latimeria chalumnae
[XP_006005911.1], fruit fly Drosophila melanogaster [NP_001261853.1], mosquito
Anopheles gambiae [XP_311364.4].
Full-length RECK amino acid sequences were aligned using Clustal Omega
Multiple Sequence Alignment web software at the European Bioinformatics Institute
(EBI) site (http://www.ebi.ac.uk/Tools/msa/clustalo/) and given a score based on
similarity. The signal sequence, structural domains of RECK (cysteine knots and Kazal
motifs), and GPI anchor were determined using the Simple Modular Architecture
Research Tool (SMART) web software (at http://smart.embl.de/). All analyses were
performed using default program settings.

2.2.4

Immunohistochemistry and Fluorescence Microscopy
Embryos were fixed in 3.7% paraformaldehyde in 1X phosphate-buffered saline

(PBS) for 2 hours at room temperature. Fixed embryos were sent to the Molecular
Pathology Core Facility at Robarts Research Institute (London, ON) for paraffin
embedding and sectioning. 10 µm de-waxed sections were probed with primary antibody
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(mouse anti-RECK, Santa Cruz, #sc-373929) followed by fluorescently-labeled
secondary antibody (Alexa Fluor goat anti-mouse IgG, Life Technologies). Slides were
mounted using ProLong Gold Antifade Mountant with 4’,6-diamidino-2-phenylindole
(DAPI) (Life Technologies). Slides were visualized using a Leica automated inverted
microscope.

2.2.5

Morpholino Design
The design and synthesis of MO were performed by Gene Tools (Philomath, OR).

A

translation-blocking

MO

(3’-CATCACATCCCCACTCCTTCTCTTC-5’)

and

splice-blocking MO (3’-CTTTTAGTTTGACTTACCAGGTGGT-5’) were engineered to
target X. laevis RECK (GenBank, AIZ00509.1). A carboxyfluoresceinated-labelled
translation-blocking MO targeted to the X. laevis β-catenin gene (3’-TTTCAACCGTTTC
CAAAGAACCAGG-5’) was also purchased from Gene Tools as a control.

2.2.6

Morpholino Microinjection
Just fertilized X. laevis embryos were transferred from 0.1X Marc’s modified

ringers (MMR) into 1X MMR containing 4% Ficoll. 2.3 nL (6 ng/nL) of splice-blocking
RECK MO or translation-blocking RECK MO were microinjected at the 1-cell stage
using 10 µm diameter glass needles. β-catenin MO (9 ng/nL) was used as a positive
control, and water-injected and un-injected embryos were used as negative controls.
Embryos were maintained in 1X MMR with Ficoll for 6 hours following injection, then
transferred to 0.1X MMR solution for rearing. Any dead or abnormal embryos 2 hours
post-injection were removed, and the remaining embryos were examined for phenotypic
abnormalities. Embryos were analyzed for 3 days following injection. Images of embryos
were taken using an Olympus SXZ9 microscope with a Nikon camera attachment.
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2.2.7

Immunoblot Analysis
RECK-MO injected and un-injected embryos from 1 dpf were collected, 1 embryo

each, and homogenized in 50 µL of radioimmunoprecipitation assay (RIPA) buffer
supplemented with phosphatase/protease inhibitors (Thermo Scientific). Protein extracts
were centrifuged at 12,000 g at 4°C for 30 minutes and the supernatant was collected.
Protein extracts were run on a 10% sodium dodecyl sulfate (SDS) polyacrylamide gel and
transferred to a polyvinylidene fluoride (PVDF) membrane. Membranes were blocked
with 0.5% bovine serum albumin (BSA) (Fisher Scientific) in tris-buffered saline with
Tween-20 (TBST) (pH 7.5) for 30 minutes at room temperature and incubated overnight
at 4°C with primary antibody (RECK, 1:200, Cell Signaling Technology, #3433; β-actin,
1:1000, Santa Cruz, #sc-47778) followed by 1 hour incubation at room temperature with
either horseradish peroxidase (HRP)-labeled goat anti-rabbit or anti-mouse secondary
antibodies (Thermo Fisher Scientific) diluted 1:10,000 in blocking solution. Signal was
detected using a SuperSignal Chemiluminescent kit (Thermo Scientific) as per the
manufacturer’s instructions. Blots were visualized using the Bio-Rad ChemiDoc Imaging
system.

2.2.8

Quantitative Real-Time PCR
To investigate changes in developmental marker genes and ECM remodeling

genes, quantitative real-time PCR was performed. 10 embryos at 1 dpf were collected
from RECK MO-injected and un-injected embryos. Total RNA was isolated using an
RNeasy Mini kit (Qiagen) according to manufacturer’s instructions. cDNA was
synthesized from 1 µg of RNA using qScriptTM CDNA SuperMix (Quanta) according to
manufacturer’s instructions. qPCR was carried out using SYBR Green PCR Master Mix
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(Applied Biosystems). For quantification, the X. laevis target genes (RECK 5’-ATGGCG
GCGGTCCCGGCCTC-3’ and 5’-ATGTGTCGTGATGTATGTGAACAG-3’, chordin
5’-AACTGCCAGGACTGGATGGT-3’ and 5’-GAAGCAACTCTAAATCCTGCC-3’,
XCG 5’-CTGTACTGGTTCACCAATAATCCC-3’ and 5’-GTGAGACGACTGCAATG
TAGC-3’, FoxD3 5’-TCTCTGGGGCAATCACACTC-3’ and 5’-CCCTTTATCAACAA
ATGTAC-3’, Xnot1 5’-GCAGGCAGAGTTCAGTTGTG-3’ and 5’-CCACAGGCAAAG
CAACTCAC-3’, ß-catenin 5’-CCCGATGAATCTGCATTGTGA-3’ and 5’-GCAAGCT
GGAACTTATCAG-3’, MMP-2 5’-CAGGGAATGAGTACTGGGTCTATT-3’ and 5’-G
TAGATGCTGCCTTTAACTGGAGT-3’, MMP-9 5’-AATCTCTTCTAGAGACTGGGA
AGGAG-3’ and 5’-TCCAGCTACTTTAGTCAATCAGCT-3’, MT1-MMP 5’-CATGGG
CAGCGATGAAGTCT-3’ and 5’-TACTTCTACAAGGGGAACAAATACTGG-3’, and
TIMP-2 5’-GCCCCCGCCCGCCCAGCC-3’ and 5’-TCGGCAGTGTGTGGGGTCTCG
GGA-3’) were normalized to the internal standard of elongation factor one alpha (EF1α
5’-CAGATTGGTGCTGGATATGC-3’

and

5’-CTAGGAGTCATCAAGGCAGT-3’)

(Krieg et al., 1998). The amplification was calculated according to the ∆∆CT method
(Livak and Schmittgen, 2001).

2.2.9

Statistical Analysis
Statistical analysis and graphing were performed using Microsoft Excel. Data is

presented as ± standard error of the mean (SEM). One-way analysis of variance
(ANOVA) followed by unpaired student’s T-tests were used. The different levels of
significance are denoted as follows: ns, p>0.05; *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001.

2.3 Results and Discussion
2.3.1

Sequence Analysis
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Since no record existed to date, I began by cloning and sequencing X. laevis
RECK. The full-length coding region of X. laevis RECK was amplified from adult lung
tissue RNA by PCR using primers designed against the X. tropicalis RECK sequence
[XM_002938937.2] and 5’ and 3’ RACE. The putative X. laevis RECK full-length
mRNA sequence was submitted to GenBank with accession # [AIZ00509.1] (Appendix
B). The derived X. laevis RECK had a full-length coding region of 2,904 bp and a
predicted protein length of 967 amino acids (Fig. 2.1a). SMART domain analysis of X.
laevis RECK was used to identify the hallmark protein domains characteristic of other
RECK proteins (Fig. 2.1a). This included an N-terminal signal sequence and a C-terminal
GPI anchor signal - both of which are removed in the mature protein. Also present were 5
characteristic cysteine knot motifs and 3 Kazal inhibitory domains. I then analyzed the
predicted X. laevis RECK protein sequence along with RECK sequences from both
vertebrate and insect species. Clustal Omega was used to align various RECK protein
sequences, and conserved amino acids that were identical for all animals were counted
(Table 2.1). Conserved RECK amino acid sequences were examined in all 31 animals
selected at the time of publication. RECK proteins had a 33% and higher amino acid
identity when compared across all vertebrates and insects. Vertebrate RECK amino acids
were 58% and higher identical, with fish, herptile and mammalian RECK being 68%,
75% and 85% and higher identical within each group. The selected bird RECK amino
acids showed the most identity with a conservation of 93% and higher.
Hallmark domains of RECK were further analyzed to determine conservation
within RECK proteins that may reveal important domain functions. One of the hallmark
domains of all RECK proteins is 3 protease inhibitor-like domains (Kazal motifs).
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Figure 2.1 X. laevis RECK amino acid sequence
(a) X. laevis RECK is 967 amino acids in length and contains an N-terminus signal
sequence and a C-terminus GPI-anchoring sequence (bold and italic). The N-terminal
region of RECK contains 5 repeats of a putative cysteine knot motif (underlined). The
middle portion of RECK contains a highly conserved 32 amino acid stretch I termed a
LAD-RSC domain (dashed underline). 3 Kazal motifs serine-protease inhibitor-like
domains (wavy underline) are found towards the C-terminus. (b) Amino acid sequence of
the described X. laevis RECK LAD-RSC domain and its Clustal Omega alignment with
other select animals. Star (*): identical amino acids are found in all sequences, colon (:):
strong similarity, period (.): weak similarity.
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(a) Predicted X. laevis RECK amino acid sequence
MKRRSGDVMHAAVRVMSASASCLGLLGIWFFLLIFLLLEAADASCCNQAKDNLMCRDVC
EQILSSKSESRIKHLLLRAPDYCPTSMIDVWTCINSSLPGVSKKSEGWVGLGCCELAIA
VECRRACKQASSQNDISKSCRKQYETALISCINRNEMGSVCCSYAGRHTNCREYCQAIF
RTDSSPGPSQIKAVENFCASISPPLVQCVNNYTQSYPMRNPVDSLYCCDRAEDPQCQSA
CKRILMSKKTEPEIVDSLSEGCTKPLPQDPLWQCFLESSRTVHSGVNIVPPPSAGLDGA
ELHCCSKANSSNCRDLCTKLYSTSWGNTQVWQEFEFACEYNPLEAPMLTCLADVREPCQ
LGCRNLTFCTNFNNRPTELFRSCNVQSDQGAMNDMKLWEKGSIKMPFMNIPVLDIKKCH
PEMWKAIACSLQIKPCHSKSRGSIICKTDCVEILTKCGDHSRFPESHTAESICELLSPS
DENEDCIPLDTYLRSSPLDNAIEEVTHPCNPNPCPANHLCEVNRKGCLPGEPCLPYFCS
QGCKLGETSDFLVRHGVLIQMPSGSVGCYKICTCGQSGTLENCLDMQCVDLHKSCLVGG
QRKNHGESFKVDCNICSCVAGTLRCSNHQCPHSEEDRRMFTGLPCNCEDQFVPVCGQNG
RTYPSACIARCVGLLDHQFEFGLCSSVCNPNPCSRNGIPKRKVCLTSYEKFGCAQYECI
PRHLKCEHSRDPMCDTENVEHINLCTLYQRGRLLSYKGSCQPFCKSAEPVCGHNGETYP
NVCSAYSDRVAVDYYGHCQDVGIFSDQGLHNECLSIQCPAIPVTVCKPIIPPGACCPLC
AGVLRILFDKEKLDTFATATKNTPITVMDILQKIRQHVSVPQCDVFGYLSMESDIIILI
VPVDSPPKSIQIDACNKEAEKINSLINSDSPTLVSQVPLSALITSEVQVSTTLNSDCNR
ICLSIHYIYLYLGIALLYVTLNA
(b) LAD-RSC domain conservation
zebra fish
coelacanth
x laevis
chicken
hummingbird
platypus
human
fruit fly
mosquito

LADVREPCQLGCKELSYCTNFNNRPTELFRSC
LADVREPCQLGCKDLTFCTNFNNRPTELFRSC
LADVREPCQLGCRNLTFCTNFNNRPTELFRSC
LADVREPCQLGCRNLSYCTNFNNRPTELFRSC
LADVREPCQLGCRNLTYCTNFNNRPTELFRSC
LADVREPCQLGCRNLTFCTNFNNRPTELFRSC
LADVREPCQLGCRNLTYCTNFNNRPTELFRSC
IESVDAPCELGCQGLSFCSNFNNRPTELFRSC
IDEVDEPCELGCDGLSFCSNFNNRPTELFRSC
: .* **:*** * :*:*************
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75%

68%

93%

85%

58%

33%

Fulllength

(37)
77%

(29)
60%

(48)
100%

(35)
73%

(15)
(31%)

(8)
17%

Kn1
(48aa)

(30)
79%

(30)
79%

(35)
92%

(35)
92%

(17)
45%

(7)
18%

Kn2
(38aa)

(40)
85%

(38)
81%

(46)
98%

(42)
89%

(28)
60%

(8)
17%

Kn3
(47aa)

(38)
79%

(34)
71%

(46)
96%

(41)
85%

(20)
42%

(11)
23%

Kn4
(48aa)

(30)
64%

(31)
66%

(45)
96%

(41)
87%

(19)
40%

(11)
23%

Kn5
(47aa)

(31)
97%

(31)
97%

(30)
94%

(29)
91%

(28)
88%

(21)
67%

LADRSC
(32aa)

(38)
83%

(31)
67%

(46)
100%

(40)
87%

(27)
59%

(19)
41%

KZ1
(46aa)

(26)
60%

(28)
57%

(36)
84%

(28)
65%

(11)
26%

(5)
12%

KZ2
(43aa)

(27)
77%

(20)
57%

(31)
89%

(21)
60%

(14)
40%

(7)
20%

KZ3
(35aa)

Table 2.1 Percent amino acid identity of select RECK domains

All

Vertebrates

Mammals

Birds

Fish

Herptile

Note: Select full-length RECK amino acid sequences were aligned with Clustal Omega. Cysteine knot (Kn) and
Kazal (KZ) motif domains were identified at http://smart.embl.de/. Clustal outputs were used to identify identical
amino acids amongst all species within a given group of animals. For the full-length sequence, the percent identity
(%) listed is the minimum amongst the group. For the various domains (whose amino acid size is indicated in
brackets), the number of identical amino acids in each aligned group (also in brackets) is represented as a
percentage of amino acid identity within that domain.
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According to Takahashi et al. (1998) only the first domain in human RECK completely
matches a Kazal motif sequence, whereas the 2nd and 3rd domains contain partial Kazal
motif sequences. A recently published in silico search of nucleotide databases revealed
the presence of members of the Kazal-family in the 4 major subphyla of the Arthropoda
(van Hoef et al., 2013). While most insect Kazal motifs contain the 6 cysteines that are
characteristic to this domain and are responsible for the formation of 1-5, 2-4, and 3-6
disulfide bridges between the 6 cysteines, only Kazal motif 1 has these 6 cysteines in
vertebrates. This conserved presence of Kazal domains in animals that have very diverse
developmental histories also suggests that such proteins may also play important roles in
general tissue maintenance, as well as in developmental processes. While SMART
domain analysis of X. laevis RECK identified only 2 Kazal motif domains (this is the
same for X. tropicalis and Drosophila RECK proteins), my analysis showed that all 3
Kazal motif domains are highly conserved and contain conserved cysteines. In agreement
with Takahashi et al. (1998), who suggested that the 1st domain best matches a classic
Kazal motif sequence, the 1st Kazal motif is best conserved in all animals and within
animal groups. Moreover, all vertebrate Kazal motifs contain the same number of amino
acids between conserved cysteines among all species examined (Appendix C). The
conservation of all cysteines in all motifs suggests that the 2 partial Kazal motifs also
contribute an important function to the protein in vertebrates. As the Kazal motifs are
protease inhibitor-like domains and play an important role in inhibiting MMPs (Chang et
al., 2008), the consistent high conservation of Kazal motif 1, and the presence of 3 such
domains in all vertebrates, suggests a conservation of RECK function as an MMP
inhibitor in these species.
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The N-terminal region of RECK contains 5 large repeats of a cysteine knot motif.
Collectively, these 5 putative cysteine knot motifs share relatively moderate similarity
among all animals (17-23%) with higher conservation of identity being seen in
vertebrates and the subgroups examined, with the most striking conservation of these
domains being in birds (Table 2.1). While in general it was cysteine knot 3 and 4 that
were the most conserved, all knot motifs in all animals had 6 conserved cysteines. This
included 2 cysteines at the beginning of each knot, a gap of 7 or 8 amino acids, followed
by the 3rd cysteine with 3 or 4 amino acids before cysteine 4. The conservation of 6
cysteines in 5 knots in all animals, with the spacing of the first 4 cysteines being almost
identical in animals ranging from insects to amphibians to mammals is quite remarkable.
The conservation in the number of cysteines and their spacing, but the dissimilarity in
amino acids between the cysteines, suggests that these motifs play structural roles that are
important to the overall functions of folded RECK proteins. While the overall RECK
protein displays high levels of sequence conservation, analysis revealed a 32 amino acid
sequence following the 5th cysteine knot that was the most conserved of any other region
of the protein. I have termed this region a LAD-RSC domain based on the first 3 (LAD)
and last 3 (RSC) amino acids. This stretch of amino acids shares no sequence similarity
with any characterized functional domain to date. This stretch of amino acids is, however,
68% identical between all of the animals I investigated, 88% identical in vertebrates, and
over 90% identical within the various vertebrate sub-groups. While domains such as the
cysteine knot and Kazal motifs are hallmarks of RECK, these hallmark domains make up
only a portion of its almost 1,000 amino acid sequence. The high conservation of other
regions, such as the LAD-RSC domain, suggest novel and as yet to be characterized roles
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for RECK, such as its roles in cell signaling (Walsh et al., 2015) - functions that are
MMP-independent and thus may not involve the Kazal motifs.

2.3.2

RECK Protein Localization
As previous research has demonstrated both a neural and vascular role for RECK

during development of fish and mouse (Oh et al., 2001; Prendergast et al., 2012), I sought
to investigate if a similar embryonic expression pattern existed for X. laevis RECK. My
previous in situ analysis revealed that RECK transcripts are present in dorsal neural
structures and the head region, such as the branchial arches, in early tailbud (stage 24)
embryos (Willson et al., 2015). To confirm neural and branchial arch RECK localization,
IHC was performed to localize RECK proteins on histological sections of late tailbud
(stage 28) embryos (Fig. 2.2). Punctate staining of RECK proteins was present in the
dorsal side of the neural tube (Fib. 2.2b). In the head region of late tailbud embryos,
RECK proteins were localized in the area of the branchial arches (Fig. 2.2d). RECK
presence in neural structures and branchial arch regions of the developing X. laevis
embryo is similar to that observed in zebrafish embryos, and consistent with the finding
that RECK plays an important role in the differentiation of neural crest cells into the
DRG (Prendergast et al., 2012). Additionally, the expression of RECK in anterior
structures coincides with the expression of ECM proteinases (stromelysin-3 and
ADAM-19) (Damjanovski et al., 2001; Neuner et al., 2009), and TIMPs (Pickard and
Damjanovski, 2004), reflecting the complex regulation of the ECM remodeling events
occurring in these anterior tissues. Further, RECK presence in the area of the branchial
arches, which will contribute to the formation of the gills, is consistent with a role for
RECK in vascular development as its localization is consistent with Xfli1, whose similar
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Figure 2.2 Localization of RECK proteins in late tailbud embryos.
IHC was performed on sections of late tailbud embryos to detect RECK protein (red).
(a), (c) Brightfield differential interference contrast (DIC) images are shown. (b) RECK
proteins are localized on the dorsal side of the neural tube and dorsal fin. (d) RECK
proteins are localized in regions consistent with branchial arches.
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expression demarks endothelial cell differentiation (Ciau-Uitz et al., 2000).

2.3.3

Functional Analysis

2.3.3.1

RECK Knockdown in X. laevis Embryos Causes Developmental
Defects

To investigate the effects of disrupting RECK expression during X. laevis
embryogenesis, RECK MO were microinjected into 1-cell stage embryos. β-catenin
MO-injected, water-injected, and un-injected embryos were used as controls. Both a
translation-blocking RECK MO and splice-blocking RECK MO were used to verify
RECK knockdown phenotypes. Confirmation of RECK knockdown using each MO was
confirmed by either Western blotting or qPCR (Fig. 2.3). Embryos were analyzed for
morphological changes in development for 3 days following RECK MO injection. The
percent survival was determined and quantified 1 dpf (st 24) and 2 dpf (st 30) (Fig. 2.4).
Over 90% of control embryos (un-injected and water-injected) developed normally,
whereas approximately 60% of RECK MO-injected embryos survived to 2 dpf (Fig. 2.4).
The surviving RECK MO-injected embryos successfully underwent gastrulation,
however, they showed severe developmental defects, including neural tube closure failure
at 1 dpf (Fig. 2.5b) axial defects and curvature at 2 dpf (Fig. 2.5d), and reduced head
structures and yolk reduction at 3 dpf (Fig. 2.5f).
My IHC analysis had revealed that RECK proteins are localized to the neural tube
and head region (Fig. 2.2). The phenotypic defects of the dorsal axis seen in RECK
MO-injected embryos coincide with the expression pattern of RECK during normal
development (Fig. 2.2). Neurulation requires tightly coordinated cell movements and
timed interactions of germ layer tissues, that of which also rely on proper ECM
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Figure 2.3 Microinjection of RECK translation-blocking or splice-blocking MO
decreased RECK levels in X. laevis embryos.
(a) Following injection of RECK translation-blocking MO (6 ng/nL) at the 1 cell stage,
protein was isolated from both RECK-MO injected and un-injected embryos 1 dpf.
Knockdown of RECK (110 kDa) protein occurred in RECK MO-injected embryos.
β-actin (42 kDa) was used as a loading control. (b) Following injection of RECK
splice-blocking MO (6 ng/nL) at the 1-cell stage, RNA was isolated from embryos 1 dpf.
RECK RNA levels were reduced in RECK MO-injected embryos compared to control.
Results are based on 3 biological replicates (mean ± SEM; technical replicates, N=9).
Data is analyzed via t-test; ***, p≤0.001.
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Figure 2.4 RECK knockdown embryos displayed reduced survival.
2.3 nl (6 ng/nL) of RECK MO was injected into X. laevis embryos at the 1-cell stage.
Following injection, embryos were scored for a normal phenotype 1 and 2 dpf. The
percent of embryos that survived following injection is graphed. Results are based on the
average of 3 biological replicates, where a minimum of 100 embryos were injected and
counted for each replicate. Bars indicate standard error (SE).
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Figure 2.5 RECK knockdown resulted in developmental defects.
RECK MO (6 ng/nL) were injected into X. laevis embryos at the 1-cell stage. Following
injection, embryos were scored for a normal phenotype 1, 2, and 3 dpf. Following
injection, photographs were taken of representative embryos. Un-injected embryos were
phenotypically normal (a,c,e). Knockdown of RECK caused neural tube closure failure at
1 dpf (b), axial defects and curvature at 2 dpf (d), and head defects at 3 dpf (f).
Abbreviations: A=anterior, CG=cement gland, H=head, NF=neural tube closure failure,
P=posterior.
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remodeling (Nikolopoulou et al., 2017). Failure of the neural tube to close can arise from
defects in cell movement as well as cell fate determination (Nikolopoulou et al., 2017).
RECK MO-injected embryos observed at stage 20 (neurula stage) exhibited a truncated
and twisted axis, with delayed neural tube fusion (Fig. 2.5b) (Appendix D). Predictably,
the failure of the neural tube to close will lead to abnormal head development in
subsequent stages, as was seen in RECK MO-injected embryos at 3 dpf (Fig. 2.5f).
The embryos that survived to 2 dpf (about 61%) exhibited axial defects and
delayed development (Fig. 2.5d). By 3 dpf (stage 40), the full effects of RECK
knockdown were evident. RECK MO-injected embryos exhibited a curved dorsal axis
and reduced yolk endoderm (Fig. 2.5f). RECK MO-injected embryos also exhibited
reduced head structures, such as the eye, however, the development of the cement gland
was unaffected (Fig. 2.5f). The cement gland is the first fully developed and most
anterior organ in the embryo and is a visual indicator that embryos have successfully
completed gastrulation (Sive and Bradley, 1996). At 3 dpf, RECK MO-injected embryos
also exhibited abnormal swelling on the ventral-lateral sides of their bodies (Fig. 2.5f).
This could be an indication of poor development of the vasculature due to RECK
knockdown, as RECK proteins were localized in the branchial arches in normally
developed embryos (Fig. 2.2), and RECK has previously been shown to play a role in
vascular development (Oh et al., 2001; Prendergast et al., 2012). Moreover, reduced head
structures observed in RECK MO-injected embryos at 3 dpf could also be attributed to
defects in neural crest cell migration. Neural crest cells contribute to a variety of
structures in the body, including craniofacial bones and cartilage, smooth muscle, and
many peripheral neurons (Mayor and Theveneau, 2013). Indeed, Prendergast et al. (2012)
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have previously shown RECK as an important modulator during neural crest cell
migration in zebrafish.

2.3.3.2

Real-Time PCR Analysis of Developmental Marker Genes in
RECK MO-Injected Embryos

To understand the morphological phenotypes observed in RECK MO-injected
embryos, real-time qPCR was performed on key developmental marker genes (chordin,
Xnot1, FoxD3, β-catenin, and XCG) at 1 dpf (stage 20). RECK MO-injected embryos at
stage 20 (1 dpf) had a significant increase in chordin mRNA levels compared to
un-injected embryos (Fig. 2.6). The chordin gene encodes a dorsal organizing protein,
important for patterning the dorsoventral axis and inducing neural structures (Sasai et al.,
1994). Xnot1 is a dorsal marker that acts upstream of chordin and plays a fundamental
role in notochord formation (Fujimi et al., 2012). FoxD3 encodes a transcription factor
important in the determination, migration, and differentiation of neural crest cells
(Cheung et al., 2005; Dottori et al., 2001; Sasai et al., 2001). The significant change seen
in chordin transcript levels coincide with the neural tube defects that occurred in RECK
MO-injected embryos. The increase in chordin mRNA levels would subsequently cause
an increase in the delineated border of cells that could give rise to the neural crest, which
would subsequently require more Xnot1 and FoxD3 transcription to give rise to neural
crest cells. Therefore, RECK MO-injected embryos may have increased the number of
neural crest cells that could potentially, but do not actually, migrate due to RECK
knockdown. This may offer an explanation to the effects of neural tube closure failure,
subsequent twisting and curving of the dorsal axis, and reduced head structures. In fact,
my results are consistent with past studies that have implicated RECK to be important
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Figure 2.6 Effect of RECK knockdown on transcript levels.
Effect of RECK knockdown on transcript levels. Real-time qPCR was used to measure
the changes in transcript levels following injection of 6 ng/nL of RECK MO into X. laevis
embryos at the 1-cell stage. Changes in transcript levels were measured relative to EF1⍺
and normalized to control (un-injected) embryos (set to 1). Results are based on the
average of 3 biological replicates (mean ± SE; technical replicates, N=9). Data is
analyzed via t-test: *, p≤0.05.
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during neural crest cell migration (Prendergast et al., 2012) and neurogenesis (Muraguchi
et al., 2007). β-catenin (a marker for gastrulation initiation) and XCG (cement gland
marker) levels did not change in RECK MO-injected embryos compared to control (Fig.
2.6), as expected, as RECK MO-injected embryos successfully underwent gastrulation.

2.3.3.3

Real-Time qPCR Analysis of ECM Remodeling Genes in RECK
MO-Injected Embryos

To further understand the morphological phenotypes observed in RECK
MO-injected embryos, real-time qPCR was performed on ECM remodeling genes that
have previously been associated with RECK function (MT1-MMP, MMP-2, MMP-9, and
TIMP-2) 1 dpf. RECK MO-injected embryos at stage 20 (1 dpf) had a significant increase
in MT1-MMP mRNA levels and a significant decrease in MMP-2 and TIMP-2 mRNA
levels compared to control (un-injected) embryos (Fig. 2.6). MMP-9 mRNA levels also
changed; however, the increase was not significant compared to control embryos
(Fig. 2.6).
MT1-MMP expression is activated early during X. laevis development at the
gastrula stage, and multiple studies have noted severe developmental defects following
disruption of endogenous MT1-MMP levels during development (Hasebe et al., 2007;
Holmbeck et al., 1999; Zhou et al., 2000). Interestingly, overexpression of MT1-MMP in
X. laevis embryos led to a similar curved dorsal axis phenotype (Hasebe et al., 2007) as I
saw in RECK MO-injected embryos (Fig. 2.5). My real-time qPCR results indicated a
significant increase in MT1-MMP transcript levels following RECK knockdown (Fig.
2.6), therefore, the morphological defects observed in RECK MO-injected embryos could
be attributed to aberrant up-regulation of MT1-MMP expression. Indeed, RECK is a

76
known inhibitor of MT1-MMP activity in vitro (Oh et al., 2001), and therefore may also
play an important MMP-inhibitory role during X. laevis development as well.
TIMP-2 is expressed from the neural stage onwards during X. laevis development.
TIMP-2 also plays an important role during development. Overexpression of TIMP-2 in
X. laevis embryos results in severe developmental defects, including neural tube closure
failure and axial defects (Nieuwesteeg et al., 2012), similar to what I saw in RECK
MO-injected embryos (Fig. 2.5). I saw a significant decrease in TIMP-2 mRNA in RECK
MO-injected embryos compared to control (Fig. 2.6), which further implies a disruption
occurred in the balance between MMPs and their inhibitors in RECK MO-injected
embryos that led to developmental defects.
It is difficult to determine the exact molecular mechanisms impacted by RECK
knockdown that led to these specific developmental defects. However, the changes that
occurred in the levels of ECM remodeling genes (MT1-MMP and TIMP-2), suggest that
RECK expression is a critical factor in regulating cell-ECM interactions during X. laevis
development.

2.4 Conclusions
This study has revealed the important developmental roles of RECK by
demonstrating its high level of evolutionary sequence conservation, developmental
localization, and functional importance. All examined animal RECK amino acid
sequences contain all hallmark domains. IHC analysis of RECK during early X. laevis
development revealed that RECK is present in dorsal and anterior structures such as the
neural tube and head region. Disrupting endogenous levels of RECK using a MO
approach in X. laevis embryos resulted in specific developmental phenotypes, including
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neural tube closure failure, axial defects, and reduced head formation. Neural tube
closure defects were further analyzed by real-time qPCR. Significant increases in chordin
mRNA levels suggest RECK knockdown impacts neural tube closure and subsequent
neural crest cell migration. Changes in important ECM remodeling genes (MT1-MMP,
MMP-2, and TIMP-2), also propose a possible explanation for the observed phenotypic
defects seen in RECK MO-injected embryos that may relate to improper ECM
degradation and remodeling. My results suggest that during X. laevis development,
RECK is an important player in neural tube closure and dorsal axis patterning.
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Chapter 3
3

Spatial Analysis of RECK, MT1-MMP, and TIMP-2 Proteins
During Early Xenopus laevis Development

This work has previously been published as: “Willson, J.A., Damjanovski, S. (2019).
Spatial analysis of RECK, MT1-MMP, and TIMP-2 proteins during early Xenopus laevis
development. Gene Expression Patterns. 34: 119066.” As per Elsevier B.V., I retain or
am hereby granted (without the need to obtain further permission) the Author Rights. The
text has been modified from the original manuscript to adhere to formatting guidelines
for this thesis. Experiments were designed and carried out by J.A.W., and S.D. provided
funding, resources, and intellectual contributions.
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3.1 Introduction
MMPs have long been classified as crucial players during vertebrate development
due to their ability to cleave components of the ECM (Visse and Nagase, 2003).
24 vertebrate MMPs have been characterized and divided into 2 distinct categories:
secreted or MT-MMPs. Each MMP has a specific substrate specificity, carrying out
distinct functions during ECM remodeling (Visse and Nagase, 2003). During
development MMPs facilitate extensive and necessary ECM remodeling events that allow
large-scale cell rearrangements and alter cell signaling. This ECM remodeling is
required, as aberrant up-regulation of MMPs has been associated with developmental
defects and death. Indeed, previous work with transgenic X. laevis embryos demonstrated
that overexpression of the MMPs - collagenase 4 (MMP-18) or stromelysin 3 (MMP-11)
- resulted in embryonic lethality (Damjanovski et al., 2001). Therefore, a delicate balance
exists between the levels of MMPs and their endogenous inhibitors, TIMPs and RECK.
Severe developmental defects have been observed when this balance is shifted towards
MMP inhibition via TIMP-2 overexpression during early X. laevis development
(Nieuwesteeg et al., 2012). While much research has examined MMP and inhibitor
activity levels with respect to large-scale cell movements, less is known about
interactions modulating cell signaling events, particularly interactions involving
pericellular molecules such as RECK, MT1-MMP, and TIMP-2.
MT1-MMP is unique in that of all MMPs only MT1-MMP null mice resulted in
death, with neonatal mice dying by 12 weeks of age due to severe skeletal and
vascularization defects (Holmbeck et al., 1999; Zhou et al., 2000). As a transmembrane
protein, MT1-MMP not only remodels the surrounding milieu, but can also interact with
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nearby cell surface receptors and facilitate intracellular signaling cascades (Deryugina et
al., 2002; Kajita et al., 2001; Seiki, 2002). A well-characterized function of MT1-MMP is
its ability to activate pro-MMP-2, a potent protease, in coordination with TIMP-2
(Fig. 1.2). TIMP-2 is unique as it remains more proximal to the cell surface in
comparison to the other 3 secreted TIMPs (Itoh et al., 2001).
RECK is another inhibitor of MMPs and is present on the cell surface as a
GPI-anchored protein (Oh et al., 2001; Takagi et al., 2009; Takahashi et al., 1998).
Expression of RECK during development is crucial, as RECK null mice were embryonic
lethal due to severe vascular defects, in part due to altered MMP activity (Chandana et
al., 2010; Oh et al., 2001). In vitro studies have shown that RECK not only attenuates the
proteolytic activity of MT1-MMP, but it can also modulate its endocytosis from the cell
surface (Miki et al., 2007), again demonstrating the functional importance of the
pericellular colocalization of these proteins.
MMPs, TIMPs, and RECK all play a crucial role during events that require
extensive ECM remodeling, such as during development and tissue repair (Lemaitre and
D’Armiento, 2006; McCawley and Matrisian, 2001; Visse and Nagase, 2003; Willson
and Damjanovski, 2014). Past studies have examined the roles of MMPs and their
inhibitors during early embryonic processes (Alexander et al., 1996; Balbı́n et al., 2001;
Pagenstecher et al., 1997; Prendergast et al., 2012; Wilson et al., 1995). Nuttall et al.
(2004) were the first to characterize the expression pattern of every mouse MMP, TIMP,
and RECK gene in different tissues throughout mouse development using qPCR analysis.
They reported high RNA levels of MT-MMPs and TIMPs, and low levels of secreted
MMPs, in most differentiated tissues, though they did not examine protein localization.
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In vitro studies have been carried out to show that MT1-MMP interacts
individually with RECK and TIMP-2 on the cell surface (Itoh et al., 2001; Miki et al.,
2007). Toward furthering our understanding of their roles in vivo, in this chapter I
investigated the localization of these 3 proteins throughout early development using IHC.
At different developmental time points (neurulation, axis elongation, and organogenesis stages 17-38), RECK, MT1-MMP, and TIMP-2 proteins show strikingly similar
localization patterns, particularly in their shifting localization from the dorsal to ventral
sides of the neural tube, and in the differentiating somite, suggesting they may function
together during specific patterning processes throughout early X. laevis development.

3.2 Materials and Methods
3.2.1

Animal Care and Rearing
Adult X. laevis were purchased from Xenopus 1, Inc (Dexter, MI). Animal rearing

and fertilizations were carried out as described in Section 2.2.1.

3.2.2

Immunohistochemistry and Fluorescence Microscopy
Embryos at stages 17, 20, 28, 34, and 38 (Fig. 1.6) were fixed as described in

Section 2.2.4. Fixed embryos were sent to the Molecular Pathology Core Facility at
Robarts Research Institute (London, ON) for paraffin embedding and sectioning.
Transverse sections (10 µm apart) were made either along the mid anterior-posterior axis
or in the anterior head region (as illustrated in Supplementary Fig. S3.1). De-waxed
sections were probed with primary antibody (mouse anti-RECK, Santa Cruz, #sc-373929;
rabbit anti-RECK, Santa Cruz, #sc-28918; rabbit anti-MT1-MMP, Santa Cruz,
#sc-30074; mouse anti-TIMP2, Santa Cruz, #sc21735) diluted 1:100 followed by
fluorescently labeled secondary antibody (Alexa Fluor goat anti-mouse and anti-rabbit

85
IgG, Thermo Fisher Scientific) diluted 1:200. Slides were mounted as described in
Section 2.2.4. Antibody validation for rabbit anti-RECK, rabbit anti-MT1-MMP, and
mouse anti-TIMP-2 was performed using Western blotting with either X. laevis whole
embryo lysate or X. laevis A6 cell lysate (Supplementary Fig. S3.2). Of note, the epitope
region of mouse anti-TIMP-2 shares 82% sequence identity with the X. laevis TIMP-2
amino acid sequence. Serial sections were probed with pairs of antibodies: RECK with
MT1-MMP, RECK with TIMP-2, and TIMP-2 with MT1-MMP. Thus, the fidelity of an
antibody’s localization could be confirmed across 2 colocalization studies. Negative
controls, following the above protocol, but without primary antibody, were performed to
analyze nonspecific binding of the secondary antibody (Supplementary Fig. S3.3). Slides
were visualized using a Leica DM16000 B microscope with Hamamatsu camera
controller (C10600) using Leica automated inverted microscope and analyzed using
Image J 2.0.0 software (NIH, Bethesda). 4 sections per embryo, from 3 embryos per stage
were analyzed for each pair of antibodies. Images are representative of 1 section from
1 embryo; however, consistent staining patterns were seen between the sections from
each embryo.

3.3 Results and Discussion
To determine the spatial expression patterns of X. laevis RECK, MT1-MMP, and
TIMP-2 proteins during development, IHC was performed on mid-anterior/posterior (AP)
axis transverse sections of embryos (the position as illustrated in Supplementary
Fig. S3.1a,b). Transverse sections through the head region on stage 38 embryos were also
examined (the position as illustrated in Supplementary Fig. S3.1c). Stages examined
included 17-20, representing neural tube closure; 28-34, tailbud stages during which axial

86
elongation is accompanied by neural and mesodermal patterning; and stage 38, when
nerve and muscle cells are differentiating, and organ formation is occurring, most notably
the eye and heart (Fig. 1.6). Because RECK, MT1-MMP, and TIMP-2 mRNA transcript
levels are low prior to and during gastrulation in X. laevis (Hasebe et al., 2007; Willson et
al., 2015), I decided to begin my analysis following gastrulation. Of note, 2 primary
RECK antibodies (mouse anti-RECK (red) and rabbit anti-RECK (green)) were used to
verify the validity of RECK localization by probing sections with both antibodies
(Supplementary Fig. S3.3). A negative control omitting primary antibodies was also
performed to demonstrate specificity (Supplementary Fig. S3.3).

3.3.1

RECK Localization During Early X. laevis Development
I have previously shown through whole mount in situ hybridization that X. laevis

RECK mRNA is present in tailbud embryos in dorsal axial structures, including the
neural tube and the eye (Willson et al., 2015). My previous analysis of RECK protein
localization using IHC on stage 28 embryos demonstrated neural and branchial arch
localization (Fig. 2.2). To expand on these results, here I examined RECK protein
localization, together with MT1-MMP and TIMP-2, throughout early X. laevis
development from stages 17 to 38.
During neural plate bending (stage 17), there was broad but weak punctate RECK
staining unassociated with specific regions (Fig. 3.1A2, 3.2A2), suggesting RECK does
not have a distinct localization in any tissue at this stage. However, at stage 20, when the
neural tube has just closed and is beginning to elongate, RECK localization was distinct
with robust staining appearing along epidermal tissues as well as along the dorsal side of
the neural tube (Fig. 3.1B2, 3.2B2). Since the neural crest resides on the dorsal side of the
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Figure 3.1. Localization of RECK and MT1-MMP proteins during early X. laevis
development.
IHC was performed using Alexa Fluor 555-labeled anti-RECK (red) and Alexa Fluor
488-labeled anti MT1-MMP (green) antibodies on stage 17-38 embryos. Brightfield DIC
images are shown in the left panel. Mono-colour images for RECK and MT1-MMP are
presented individually. Colocalization of RECK and MT1-MMP (yellow) is shown on the
right panel. Dotted line in stage 28 merged image indicates overlapping signal within the
middle of somites. Dashed line in stages 34 and 38 merged images indicates overlapping
signal along the ventral neural tube. Scale bar= 100 µm. Abbreviations: E=endoderm,
Ep=epidermis, D=dorsal NT, DF=dorsal fin, N=notochord, NC=neural crest, NP=neural
plate, NT=neural tube, S=somitic mesoderm, V=ventral NT.
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Figure 3.2. Localization of RECK and TIMP-2 proteins during early X. laevis
development.
IHC was performed using Alexa Fluor 488-labeled anti RECK (green) and Alexa Fluor
555-labeled anti-TIMP-2 (red) antibodies on stage 17-38 embryos. Brightfield DIC
images are shown in the left panel. Mono-colour images for RECK and TIMP-2 are
presented individually. Colocalization of RECK and TIMP-2 (yellow) is shown on the
right panel. Dotted line in stage 28 merged image indicates overlapping signal within the
middle of somites. Dashed line in stages 34 and 38 merged images indicates overlapping
signal along the ventral neural tube. Scale bar= 100 µm. Abbreviations: E=endoderm,
Ep=epidermis, D=dorsal NT, DF=dorsal fin, N=notochord, NC=neural crest, NP=neural
plate, NT=neural tube, S=somitic mesoderm, V=ventral NT.
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neural tube upon closure (Le Douarin and Kalcheim, 1999), it appears that RECK
proteins are present within neural crest cells at this stage (Fig. 3.1B2 and Fig. 3.2B2). This
is evident in Fig. 3.2B2 (arrow) where RECK staining appears to localize in cells that are
located along the periphery of the neural tube, not within the neural tube itself, in
agreement with the known migratory path of neural crest cells (Le Douarin and
Kalcheim, 1999). Indeed, RECK is essential during neural crest cell migration in
zebrafish (Prendergast et al., 2012), and I have previously shown RECK mRNA and
protein staining within the head and branchial arches, structures in the embryo where
neural crest cells are known to migrate (Lumsden et al., 1991; Tosney, 1982).
There was also faint RECK staining in endodermal cells at stage 20 embryos
(Fig. 3.1B2,

3.2B2).

At

stage

28,

when

axis

elongation

is

prevalent

and

mesodermal/neural tissues are being patterned, RECK proteins were localized in the
dorsal epidermis and within most areas of the neural tube (Fig. 3.1C2, 3.2C2), which is
consistent with my past in situ data of RECK (Willson et al., 2015). RECK also localized
to the middle portion of the somitic mesoderm. (Fig. 3.1C2, 3.2C2). This horizontal
RECK expression domain in the middle of the somite lies across the differentiating
dermatomes, myotomes, and sclerotomes, which are differentiating vertically. This
suggests RECK is present briefly in the mid-region of the dermatomes, myotomes, and
sclerotomes as they are being differentiated; in agreement with past studies that have
shown RECK as a regulator of myogenesis in vitro (Echizenya et al., 2005).
By late tailbud stages (stage 34), RECK staining was absent in the somites, but
appeared in the cells surrounding the notochord (Fig. 3.1D2, 3.2D2). Also at stages 34 and
38, RECK localization shifted from being present within the entire neural tube (stage 28),
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to becoming more pronounced along the ventral side of the neural tube (stages 34)
(Fig. 3.1C2-E2, 3.2C2-E2). RECK staining was also present in the anterior (head) region of
stage 38 embryos in the epidermis and eye region, consistent with my past in situ data
(Willson et al., 2015), and as with the mid AP-axis sections, along the ventral side of the
neural tube (Fig. 3.4A2, B2).
Given that RECK has been implicated to play a role in neurogenesis in mice
(Muraguchi et al., 2007), it is consistent with my results that show RECK proteins
localize to the epidermis and neural tube during X. laevis development. Neurulation
involves ectodermal migration, patterning, and differentiation of neural tissue. This
patterning, particularly the dorsoventral (D-V) patterning of the neural tube after closure,
is well characterized and involves dorsal BMP signals and ventral Shh signals (De
Robertis and Kuroda, 2008). Ventral Shh signals are responsible for motor neuron
differentiation and dorsal BMP signals are responsible for sensory neurons, with
interneurons present in between. The distinct shift in RECK localization from the dorsal
(stage 20), to entire (stage 28), to ventral side (stage 34) of the neural tube implicates its
role in D-V differentiation, though not of any specific neuron type. Here, I found that
RECK proteins appear to be present when patterning and differentiation events are
occurring.

3.3.2

MT1-MMP Localization During Early X. laevis Development
Following RECK protein localization, I next examined MT1-MMP localization.

While MT1-MMP has been associated with events that encompasses extensive ECM
degradation and remodeling, including important roles during frog metamorphosis

93
(Hasebe et al., 2007; Jung et al., 2002; Patterton et al., 1995), MT1-MMP protein
localization within X. laevis neurulation has not been examined.
During neurulation (stages 17 and 20), MT1-MMP protein staining displayed a
strikingly similar localization pattern as RECK. At stage 17, prior to neural tube
formation, there was punctate MT1-MMP staining that was not associated with distinct
tissues (Fig. 3.1A3, 3.3A3). However, at stage 20 following neural tube closure,
MT1-MMP proteins localized to the dorsal side of the neural tube and along the
epidermal tissue (Fig. 3.1B3, 3.3B3). This staining pattern on the dorsal side of the neural
tube appears to be localized where neural crest cells reside, similar to what I saw with
RECK. This is not surprising, since recently MT1-MMP has been shown to be required
for proper neural crest cell migration during X. laevis development (Garmon et al., 2018).
At stage 28, MT1-MMP staining was distinct, localizing to the entire neural tube,
somitic mesoderm, and epidermis (Fig. 3.1C3, 3.3C3). During the late tailbud stages
(stages 34 and 38), MT1-MMP staining disappeared from the somites, became more
robust along the epidermis, and shifted to the ventral side of the neural tube
(Fig. 3.1D3-E3, 3.3D3-E3). MT1-MMP also exhibited staining in the anterior (head)
region of stage 38 embryos in the epidermis, eye region, and, as with the mid AP-axis
sections, along the ventral side of the neural tube (Fig. 3.4A3, C3). Like RECK,
MT1-MMP was present transiently in the middle of somites at stage 28, with a distinct
shift in MT1-MMP localization from the dorsal (stage 20), to entire (stage 28), to ventral
side (stage 34) of the neural tube during the tailbud stages. These observations implicate
a role for MT1-MMP in patterning and differentiation.
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Figure 3.3. Localization of TIMP-2 and MT1-MMP proteins during early X. laevis
development.
IHC was performed using Alexa Fluor 555-labeled anti-TIMP-2 (red) and Alexa Fluor
488-labeled anti MT1-MMP (green) antibodies on stage 17-34 embryos. Brightfield DIC
images are shown in the left panel. Mono-colour images for TIMP-2 and MT1-MMP are
presented individually. Colocalization of TIMP-2 and MT1-MMP (yellow) is shown on
the right panel. Dotted line in stage 28 merged image indicates overlapping signal within
the middle of somites. Dashed line in stage 34 merged image indicates overlapping signal
along the ventral neural tube. Scale bar= 100 µm. Abbreviations: E=endoderm,
Ep=epidermis, D=dorsal NT, DF=dorsal fin, N=notochord, NC=neural crest, NP=neural
plate, NT=neural tube, S=somitic mesoderm, V=ventral NT.

95

DIC

St17

St 20

St 28

St 34

St 38

TIMP-2

MT1-MMP

Merged

96
Figure 3.4. Localization of RECK, MT1-MMP, and TIMP-2 proteins in the anterior
region of stage 38 X. laevis embryos.
IHC was performed using Alexa Fluor 555-labeled anti-RECK and anti TIMP-2 (red) and
Alexa Fluor 488-labeled anti-MT1-MMP and anti-RECK (green) antibodies on stage 38
embryos. Brightfield DIC images are shown in the left panel. Mono-colour images for
RECK, MT1-MMP, and TIMP-2 are presented individually. Colocalization of RECK and
MT1-MMP, RECK and TIMP-2, or TIMP-2 and MT1-MMP (yellow) is shown on the
right panel. Scale bar= 100 μm. Abbreviations: E=endoderm, NT=Neural tube.
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3.3.3

TIMP-2 Localization During Early X. laevis Development
TIMP-2 not only inhibits MMPs but has also been associated with a number of

cell signaling pathways due to its pericellular localization (Stetler-Stevenson 2008). I
have previously shown that TIMP-2 overexpression in X. laevis embryos resulted in
severe developmental defects and death (Nieuwesteeg et al., 2012). To further elucidate
the role of TIMP-2 during development, I analyzed the spatial localization of TIMP-2
proteins in X. laevis embryos.
During neurulation (stages 17 and 20), while present in the ectoderm and dorsal
side of the neural tube, TIMP-2 proteins were localized to a number of tissues including
somitic mesoderm and endoderm (Fig. 3.2A3, B3 and 3.3A2, B2). As I saw with RECK
and MT1-MMP, TIMP-2 staining also occurred along the dorsal side of the neural tube
where the neural crest resides (Fig. 3.2A3, B3 and 3.3A2, B2), which coincides with past
studies implicating a role for TIMP-2 in the migration of neural crest cells in chick
(Cantemir et al., 2004).
In the tailbud (stage 28), there was robust TIMP-2 staining in the entire neural tube, the
middle of the somites, and epidermis (Fig. 3.2C3, 3.3C2), similar to RECK and
MT1-MMP. By stage 34, TIMP-2 staining within the neural tube decreased and shifted
ventrally, was greatly reduced in the somites, but persisted in the epidermis. Punctate
TIMP-2 staining also appeared in some endodermal cells during these stages (Fig. 3.2D3,
3.3D2). By stage 38, TIMP-2 again exhibited punctate staining within the entire neural
tube, as well as the eye (Fig. 3.4B3, C2). Like RECK and MT1-MMP, TIMP-2 was
present transiently in the middle of somites at stage 28, with a distinct shift in TIMP-2
localization from the dorsal (stage 20), to entire (stage 28), to ventral (stage 34) side of
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the neural tube during the tailbud stages, which also implicates a role for TIMP-2 in
patterning and differentiation.

3.3.4

RECK, MT1-MMP, and TIMP-2 Exhibit Similar Localization
Patterns
The relationship between MT1-MMP, RECK, and TIMP-2 has been examined in

vitro, however, due to the complex nature of amniote vertebrate embryos and the
redundant functions of MMPs and TIMPs, it has been difficult to elucidate any
cooperative roles they may play in vivo. Here, the examination of anamniote frog
embryos allows us to examine their localization in very early developmental processes.
RECK, MT1-MMP, and TIMP-2 exhibited distinct overlapping expression
patterns throughout all stages examined (summarized in Table 3.1). Shortly after neural
tube closure (stage 20) and in early tailbud stages, RECK, MT1-MMP, and TIMP-2
proteins were localized to the dorsal side of the neural tube and along the epidermal
tissue (Fig. 3.1B4, 3.2B4, 3.3B4). The localized staining of all 3 proteins at the most dorsal
spot of the neural tube and alongside the left and right periphery of the neural tube
suggest they are present within the neural crest cell migration domains (Fig. 3.1B4, 3.2B4,
3.3B4). Without the use of a neural crest cell marker, however, the migration of this
transient population of cells could not be observed in later stages (stages 28-38). Since all
3 proteins have been implicated individually to play an important role in the migration of
neural crest cells (Cantemir et al., 2004; Garmon et al., 2018; Prendergast et al., 2012),
future work examining if MT1-MMP, TIMP-2, and RECK interact with each other to
properly regulate neural crest cell migration would be of great interest.
At stage 28, when somitogenesis (segmentation and differentiation) is ongoing,
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Table 3.1: Summary of the spatial expression pattern of RECK, MT1-MMP, and
TIMP-2 proteins in various tissue types throughout early X. laevis developmental
stages.
Tissue Type

Neurula
(Stages 18-20)

Early Tailbud
(Stage 28)

Late Tailbud
(Stages 34-38)

Epidermis

RECK
MT1-MMP
TIMP-2

RECK
MT1-MMP
TIMP-2

RECK
MT1-MMP
TIMP-2

Neural Tube

RECK
MT1-MMP
TIMP-2

RECK
MT1-MMP
TIMP-2

RECK
MT1-MMP
TIMP-2

Somites

TIMP-2

RECK
MT1-MMP
TIMP-2

RECK
MT1-MMP
TIMP-2

Notochord

-----

-----

-----

Endoderm

RECK
MT1-MMP
TIMP-2

-----

RECK
MT1-MMP
TIMP-2

Eye Region

N/A

RECK
MT1-MMP
TIMP-2

RECK
MT1-MMP
TIMP-2
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all 3 proteins localized to the middle of the somitic mesoderm (Fig. 3.1C4, 3.2C4, 3.3C4).
By stages 34 and 38, when signals for myotome, dermatome, and sclerotome
specification are largely complete, RECK, MT1-MMP, and TIMP-2 localization within
the somites is reduced while at the same time their localization within the neural tube
shifts to the ventral side (Fig. 3.1-3.3D4-E4). All 3 proteins also localize in endodermal
tissues in the late tailbud stages (Fig. 3.1-3.3D4-E4).

3.4 Conclusions
Due to their highly similar localization patterns throughout X. laevis development,
my results suggest that RECK, MT1-MMP, and TIMP-2 function together during
different developmental events to influence cell behaviour and ECM remodeling. Despite
the original description of MMPs as enzymes that remodel the ECM, and TIMPs and
RECK as inhibitors of this process, the pericellular localization of MT1-MMP, RECK,
and TIMP-2 suggests that they have regulatory activities independent of their ECM
remodeling role. Indeed, similar to the expression analysis of Nuttall et al. (2004), where
they suggest that MT-MMPs are expressed in cells that are in an active state and high
expression of TIMPs are associated with the maintenance of tissue integrity, here, I see
colocalization of MT1-MMP, TIMP-2, and RECK in later developmental stages in which
tissues undergo patterning and differentiation (Table 3.1). While my findings do not
preclude the modulation of ECM remodeling, my data do support an additional important
role for these proteins in the patterning and differentiation of the neural tube and somites.
Early embryogenesis requires the control of cell proliferation, cell migration,
differentiation and ultimately distinct cell functions - processes that need to be
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coordinated by molecules that govern such events - molecules such as RECK,
MT1-MMP, and TIMP-2.
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3.5 Supplementary Data
Figure S3.1 Schematic diagram representing the location of the transverse sections
on X. laevis embryos.
Transverse sections (10 µm apart) were made in the mid anterior-posterior axis (as
delineated by the boxes) of (a) neurulating embryos (stages 17 and 20) and (b) early/late
tailbud embryos (stages 28, 34, and 38). (c) Transverse sections (10 µm apart) were made
in the anterior head region (as delineated by the box) in late tailbud embryos (stage 38).
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Figure S3.2 Validation of antibodies using Western blotting.
(a) A blot probed with human rabbit anti-RECK shows a specific band at the expected
molecular weight (110 kDa) in X. laevis A6 cell lysate. (b) A blot probed with human
mouse anti-TIMP-2 shows a specific band at the expected molecular weight (21 kDa) in
X. laevis A6 cell lysate. (c) A blot probed with human rabbit anti-MT1-MMP shows a
specific band at the expected molecular weight (63 kDa) in X. laevis whole embryo
lysate.
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Figure S3.3 Validity of antibodies.
IHC was performed using only secondary antibodies (Alexa Fluor 555-labeled
anti-mouse (red) and Alexa Fluor 488 anti-rabbit (red)) and costained with DAPI (blue)
on stage 34 embryos to establish specificity in the experiment (right panels). Sections
were also probed with both primary RECK antibodies used in these experiments (Alexa
Fluor 555-labeled mouse anti-RECK (red) and Alexa Fluor 488 labeled rabbit anti-RECK
(green)) and costained with DAPI (blue) to validate their specificity. Colocalization is
indicated on the bottom right panel (yellow). Brightfield DIC images are shown on the
left panels.
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Chapter 4
4

Modulation of RECK Levels in Xenopus A6 Cells: Effects on
MT1-MMP, MMP-2 and pERK Levels

This work is in press as “Willson, J.A., Bork. B., Muir, C.A., and Damjanovski, S.
(2019). Modulation of RECK levels in Xenopus A6 cells: effects on MT1-MMP, MMP2, and pERK levels. Journal of Biological Research. DOI: 10.1186/s40709-19-0108-8.”
The text has been modified from the original manuscript to adhere to formatting
guidelines for this thesis. Experiments were designed and carried out by J.A.W. B.B.
assisted with zymography and C.A.M. assisted with qPCR as part of their 4999E honours
thesis projects. S.D. provided funding, resources, and intellectual contributions.
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4.1 Introduction
Remodeling of the ECM primarily occurs through the combined action of MMPs
and their endogenous inhibitors, TIMPs, and RECK (Visse and Nagase, 2003). The
RECK gene encodes a GPI-anchored protein with 3 protease inhibitor-like domains called
Kazal motifs. RECK was initially classified as a tumour suppressor protein due to its
ability to suppress metastasis when ectopically expressed in transformed cells (Takahashi
et al., 1998). In vitro studies have shown that RECK can inhibit MMP-2 and MMP-9,
secreted gelatinases associated with important developmental events and diseases, as well
as MT1-MMP, a multi-functional cell surface MMP (Takagi et al., 2009; Takahashi et al.,
1998; Oh et al., 2001). Many studies have investigated the embryonic role of MMPs.
Perhaps due to redundant functions between family members, mice knockouts of each
MMP, apart from MT1-MMP, and all TIMPs are viable (Amar et al., 2017). This
positions MT1-MMP as a uniquely important molecule, and therefore its regulation by
other agents, such as RECK, is of interest. Likewise, studies have implicated the
importance of RECK during development, as RECK knockout in mice is embryonic
lethal. In both mice and fish, loss or knockdown of RECK causes defects in angiogenesis
and neurogenesis, in part due to aberrant regulation of MMPs (Chandana et al., 2010;
Muraguchi et al., 2007; Oh et al., 2001; Prendergast et al., 2012). In addition, RECK has
been shown to play a role in cell migration signaling pathways independent of its
MMP-inhibitory role (Walsh et al., 2015).
Previous studies using epithelial breast cancer cells have revealed a complex
pattern of expression between MT1-MMP levels and ERK activation into pERK, as well
as pro-MMP-2 activation into MMP-2 (Cepeda et al., 2016; 2017; Willson et al., 2017).
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MCF-7 cells stably expressing extremely high levels of MT1-MMP demonstrated low
ERK activation and high pro-MMP-2 activation. Conversely, cells with low levels of
MT1-MMP demonstrated high ERK activation and low pro-MMP-2 activation (Cepeda et
al., 2016). Treatment with the broad spectrum MMP inhibitor Batimastat (BB94)
increased MT1-MMP expression, but decreased MMP-2 activation and did not alter
pERK protein levels (Cepeda et al., 2017). In MDA-MB-231 cells, inhibition of
pro-MT1-MMP activation elevated global MT1-MMP and pERK levels, but decreased
MMP-2 levels (Willson et al., 2017). These studies demonstrated that when MT-MMP
levels are altered, pERK and MMP-2 activation levels alter in different ways depending
on treatment. This suggests a mechanism that may involve more molecules than just
MT1-MMP in the activation of ERK and pro-MMP-2, with RECK possibly playing an
important role. I have cloned (Fig. 2.1) and characterized RECK expression during
X. laevis development (Fig. 2.2), showing that RECK is present at stages where ECM
remodeling events are associated with neural function. My recent in vivo examination of
RECK, MT1-MMP, and TIMP-2 show that these proteins colocalize in the dorsal axis of
X. laevis tailbud embryos, particularly in the neural tube (Fig. 3.1-3.4). Several other
studies have also described interactions between RECK and MT1-MMP proteins in vivo
and in vitro (Dong et al., 2010; Nambiar et al., 2016; Tang et al., 2018), with RECK
being shown to complex with MT1-MMP at the cell surface to both attenuate its
proteolytic activity and modulate its endocytosis from the cell surface (Miki et al., 2007).
To corroborate past in vitro work that link MT1-MMP and pERK levels, as well
as build on my X. laevis in vivo localization of MT1-MMP and RECK, in this chapter I
used an in vitro examination of X. laevis A6 epithelial cells, one of the few in vitro cell
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types available for X. laevis, to confirm the importance of RECK as it relates to
MT1-MMP, pERK, and MMP-2 protein levels. I used a MO approach to knock down
RECK levels, plasmid transfection to overexpress RECK, and PI-PLC treatment to cleave
RECK proteins from the surface of A6 cells. RECK knockdown did not alter MT1-MMP
protein levels, ERK activation, or MMP-2 activity levels. RECK overexpression and
PI-PLC treatment both resulted in increased MT1-MMP protein levels and MMP-2
activity levels. Only RECK overexpression decreased pERK protein levels in A6 cells.
From these results, it is suggested that optimal levels of RECK present on the cell surface
are important for modulating MT1-MMP protein levels and MMP-2 activation.

4.2 Materials and Methods
4.2.1

Morpholino Design
The design and synthesis of MOs were carried out as described in Section 2.2.1.

A translation-blocking RECK MO and β-catenin MO were engineered as described in
Section 2.2.1. Standard scrambled MO (antisense: 3’-CCTCTTACCTCAGTTACAATTT
ATA-5’) were also purchased from Gene Tools as an additional control.

4.2.2

Cell Culture Conditions, Endo-Porter Treatments, Transfections,
and PI-PLC treatments
X. laevis A6 cells (ATCC®CCL-102TM) were maintained at 24°C in Leibovitz’s

L-15 Medium (Wisent Inc.) containing 10% fetal bovine serum (FBS) and 1% penicillin
(100 U/mL)/streptomycin (100 μg/mL) (Fox et al., 2014).
For RECK knockdown, cells were seeded on 35 mm dishes at a density of
1x106 cells. After 24 hours, spent culture medium was replaced with medium containing
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Endo-Porter reagent and MO oligos (Gene Tools) according to manufacturer’s
instructions. 48 hours following treatment, cell lysates were collected in RIPA buffer.
MOs were used in dosages of 1, 10, or 20 μM. Following confirmation of RECK protein
decrease, 20 μM MO treatment was used in subsequent experiments.
For RECK overexpression, cells were seeded as above. 24 hours later, cells were
transfected with hemagglutinin (HA)-tagged RECK in pcDNA3.1 using Lipofectamine
2000 (Thermo Fisher) according to manufacturer’s instructions. Another 24 hours
following transfection, cell lysates were collected using RIPA buffer. The generation of
the full-length RECK cDNA construct is described in Section 2.2.2, with the HA tag
being inserted just following the N-terminal signal sequence such that it would not be
removed during secretion, nor would it interfere with GPI anchor formation at the
C-terminal end.
PI-PLC is an enzyme from Bacillus cereus that cleaves GPI-linked proteins, such
as

RECK,

from

the

plasma

membrane.

24

hours

following

transfection,

RECK-transfected and mock-transfected (Lipofectamine only) cells were treated with
100 U/mL of PI-PLC (Thermo Fisher) in serum-free L-15 media according to
manufacturer’s instructions. 24 hours following PI-PLC treatment, cell lysates were
collected using RIPA buffer.

4.2.3

Quantitative Real-Time PCR
To investigate changes in transcript levels, real-time qPCR was performed. Cells

were seeded and treated as described in Section 4.2.2. Following treatment, RNA was
extracted from cells using an RNeasy Mini Kit (Qiagen) according to manufacturer’s
instructions. cDNA was synthesized and qPCR was carried out as described in Section
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2.2.8. For quantification, the target genes (MMP-2, MMP-9, MT1-MMP, and TIMP-2)
were normalized to the internal standard of EF1α (Krieg et al., 1998). Primer sequences
are described in Section 2.2.8. Fold change was calculated according to the ∆∆CT
method (Livak and Schmittgen, 2001).

4.2.4

Immunoblot analysis
To investigate changes in RECK, MT1-MMP, and pERK protein levels,

immunoblotting was performed. Cells were seeded and treated as described in Section
4.2.2. Following treatment, cells were washed 2X with PBS (pH 7.2) and disrupted using
modified RIPA buffer. Collected cell lysates were shaken on ice for 20 minutes and
sonicated 3X for 10 seconds each. Protein level was quantified using a bicinchoninic acid
(BCA) assay (Thermo Scientific). 10 µg of protein per sample was mixed with 4X
loading dye and subjected to a 10% SDS polyacrylamide gel and transferred to a PVDF
membrane as described in Section 2.2.7. Membranes were blocked and probed with
primary antibody (RECK, 1:200, Cell Signaling Technology, #3433; HA, 1:500, Santa
Cruz, #sc-7392; MT1-MMP, 1:200, Millipore, #AB6004; pERK, 1:16000, Cell Signaling
Technology, #4370; total ERK1/2, 1:4000, Cell Signaling Technology, #4695; β-actin,
1:1000, Santa Cruz, #sc-47778) followed by secondary antibody as described in Section
2.2.7. Signal was detected and quantified as described in Section 2.2.7. ERK1/2
activation is presented as a ratio between pERK and total ERK1/2 band intensities.

4.2.5

Gelatin Zymography
To measure the activity of secreted MMP-2 and MMP-9 proteins, gelatin

zymography was performed. Cells were seeded and treated as described in 4.2.2.
24 hours later, culture media was replaced with serum-free L-15 media. 24 hours
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following serum-free treatment, serum-free media was collected and mixed with 2X
SDS-loading dye in a 1:1 ratio, with only 5 μL of sample being loaded into the gel
(Hawkes and Taniguchi, 2010). To aid in the identification of active versus inactive
forms of a MMP, the broad spectrum MMP inhibitor BB94 (10μM) was added to
duplicate samples. Media samples were run on an SDS-containing 15% polyacrylamide
gel, co-polymerized with 1% gelatin, at 140 V for 6 hours. A Triton X-100 (2.5%)
incubation was then used to renature MMP-2 and MMP-9 proteins. Gels were placed in
developing buffer (pH 7.5, 50 mM Tris, 200 mM NaCl, 5 mM CaCl2, and 0.02% Brij-35)
at 37°C with gentle shaking. After 48 hours, gels were stained with 0.5% Coomassie blue
for 1 hour followed by de-staining (50% methanol) for 2 hours. Gels were visualized and
band intensities representative of enzyme activity were quantified using Bio-Rad
ChemiDoc Imaging system and Bio-Rad Image Lab software.

As protein used for

zymography was isolated from the media, the use of an internal (loading) standard was
not possible. Accordingly, the ratio of active over total (pro, intermediate, and active)
forms was determined for MMP-2. These ratios (active MMP-2/total MMP-2) were then
used to calculate the percentage change of MMP-2 activation levels between control and
treated cells.

4.2.6

Statistical Analysis
Statistical analysis and graphing were performed using Microsoft Excel. Data is

presented as mean ± SD, except for qPCR results in Fig. 4.7 which are ± SEM. One-way
ANOVA followed by unpaired student’s T-tests were used and indicated respectively in
each figure legend. The different levels of significance are denoted as follows: ns,
p>0.05; *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001; ****, p ≤ 0.0001.
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4.3 Results
4.3.1

RECK Knockdown in A6 Cells Did Not Alter MT1-MMP or
pERK Protein Levels nor MMP-2 Activity Levels
To confirm that the RECK MO treatment decreased RECK, protein level in

X. laevis A6 cells was measured following treatment with different concentrations of
RECK MO. Immunoblotting demonstrated that RECK protein is endogenously expressed
in untreated A6 cells. A dose-dependent decrease in cellular RECK protein level was then
seen following treatment of increasing concentrations of RECK MO. (Fig. 4.1a). The
decrease in RECK was significant when immunological signals were quantified, with the
20 µM treatment reducing RECK protein levels by approximately 60%. (Fig. 4.1b).
Having confirmed the efficacy of the RECK MO, I examined the levels of MMPs and
their activity levels in A6 cells following RECK knockdown. RECK knockdown did not
alter MT1-MMP (Fig. 4.2a) nor pERK protein levels (Fig. 4.2b) as shown by immunoblot
analysis. However, this 60% knockdown in RECK was large enough to cause a cellular
effect, as there was a change in transcription levels (Fig. 4.3).
Zymography was then used to quantify the active and inactive secreted forms of
MMP-2 and MMP-9 after RECK knockdown. Bands of gelatin degradation representative
of MMP activity of specific molecular mass on zymograms were quantified. The addition
of the broad spectrum MMP inhibitor BB94 was used to confirm the identity of active
MMP-2 versus pro-MMP-2 and intermediate MMP-2 forms (Appendix E). The amount
of the active form of MMP-2 was compared to the total amount of MMP-2 (pro-,
intermediate, and active forms). The active/total MMP-2 ratio was set to 1 in control
cells. The relative level of MMP-2 activity did not change (there was the same ratio
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Figure 4.1. Treatment of A6 cells with RECK MO resulted in decreased RECK
protein levels.
Immunoblot analysis was used to confirm knockdown of RECK following treatment of
A6 cells with RECK MO using Endo-porter delivery reagent. Protein was extracted from
cells 48 hours following treatment with increasing concentrations of RECK MO.
(a) Knockdown of RECK protein occurred in a dose-dependent manner. β-actin was used
as a loading control. (b) Quantification of protein levels in (a) were graphed and data are
based on 3 biological replicates (mean ± SD) and normalized to control (set to 100%).
Data are analyzed via t-test; *, p≤0.05; ***, p≤0.001; ****, p≤0.0001.
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Figure 4.2. RECK knockdown did not alter MT1-MMP or pERK protein levels or
MMP-2 activity levels.
(a) Densitometry quantification of MT1-MMP immunoblotted protein normalized to
β-actin. MT1-MMP protein levels did not significantly change in RECK knockdown cells
compared to control (set to 1). β-actin was used as a loading control. b) Densitometry
quantification of pERK normalized to total ERK levels. pERK protein levels did not
significantly change in RECK knockdown cells compared to control (set to 1). (c) Gelatin
zymography was used to measure protein activity of secreted pro-, intermediate, and
active MMP-2 following RECK knockdown in A6 cells. Data are presented as the ratio
between active and total (pro-, intermediate, and active) MMP-2 levels between control
and RECK knockdown cells. Active/total MMP-2 levels did not significantly change in
the media of RECK knockdown cells compared to control (set to 1). Graphed data are
based on 3 biological replicates (mean ± SD). Data are analyzed via t-test; ns, p>0.05.
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Figure 4.3. Effect of RECK knockdown on MMP-2, -9, MT1-MMP, and TIMP-2
mRNA levels.
Following RECK knockdown in A6 cells, MMP-2, MMP-9, and MT1-MMP mRNA
levels did not change significantly compared to control, however, TIMP-2 mRNA levels
decreased significantly. Changes in gene expression were measured relative to EF1α and
normalized to control cells (set to 1). Results are based on 3 biological replicates (mean
± SEM; technical replicates, N=9). Data are analyzed via t-test; **, p≤0.01.
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of active to total MMP-2) after RECK knockdown (Fig. 4.2c). MMP-9 activity could not
be detected in the media (Appendix F) at the previously described molecular masses:
84 kDa (Cepeda et al., 2016; Nieuwesteeg et al., 2014) or 73 kDa (Fujimoto et al., 2006).

4.3.2

RECK Overexpression in A6 Cells Caused an Increase in
MT1-MMP Protein Levels and Relative Active MMP-2 Levels,
and a Decrease in pERK Protein Levels
After observing no change in MT1-MMP, pERK, and MMP-2 activation

following RECK knockdown, I proceeded with overexpression of RECK in A6 cells.
Transfection of an HA-tagged RECK construct was confirmed, as the level of RECK
protein in transfected cells significantly increased (Fig. 4.4). This increase in protein was
detected and quantified using both a RECK and HA antibody (Fig. 4.4).
As was done with the knockdown treatment, cellular proteins of interest were
quantified following RECK overexpression. Although no change was observed following
RECK knockdown, RECK overexpression resulted in a significant increase in the level of
MT1-MMP protein (Fig. 4.5a) as well as a significant decrease in the level of pERK
protein (Fig. 4.5b). Following RECK overexpression, zymography of secreted proteins
revealed a significant increase in the relative level of active MMP-2 (Fig. 4.5c). Secreted
MMP-9 proteins could not be detected via zymography.

4.3.3

Treatment With PI-PLC Reduced Cell-Surface RECK Levels
PI-PLC treatment (which releases GPI-linked proteins) was used to cleave RECK

from the cell surface, and also allowed us to confirm the proper trafficking and
localization of overexpressed RECK protein to the cell surface in the A6 cells. As
expected, PI-PLC treatment significantly reduced the level of membrane localized
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Figure 4.4. Transfection of full-length HA-tagged RECK constructs in A6 cells
resulted in increased RECK levels.
Immunoblot analysis was used to confirm overexpression of RECK protein following
transfection with RECK cDNA constructs. Mock-transfected and GFP-transfected A6
cells were used as controls. Protein was extracted from cells 24 hours following
transfection. β-actin was used as a loading control. Top panel shows increased levels of
RECK protein compared to control using a RECK antibody, while bottom panel confirms
the presence of HA-tagged proteins only in RECK-transfected A6 cells using an HA
antibody. Graphed data of top panel are based on 3 biological replicates (mean ± SD) and
normalized to control (set to 100%). Data are analyzed via t-test; ***, p≤0.001.
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Figure 4.5. RECK overexpression increased MT1-MMP protein and MMP-2 activity
levels and decreased pERK protein levels.
(a) Densitometry quantification of immunoblots of MT1-MMP protein normalized to
β-actin. MT1-MMP protein levels significantly increased in RECK-overexpressing cells
compared to control (mock-transfected cells) (set to 1). (b) Densitometry quantification
of pERK normalized to total ERK levels. pERK protein levels significantly decreased in
RECK-overexpressing cells compared to control (set to 1). (c) Gelatin zymography was
used to measure protein levels of secreted pro-, intermediate, and active MMP-2
following RECK overexpression in A6 cells. Data are presented as the ratio between
active and total (pro-, intermediate, and active) MMP-2 levels between control and
RECK-overexpressing cells. Active/total MMP-2 levels significantly increased in the
media of RECK-overexpressing cells compared to control (set to 1). Graphed data are
based on 3 biological replicates (mean ± SD). Data are analyzed via t-test; *, p≤0.05; **,
p≤0.01.
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RECK, both in control and RECK-overexpressing cells (Fig. 4.6).

4.3.4

PI-PLC Treatment of A6 Cells Caused an Increase in MT1-MMP
and Relative Active MMP-2 Levels
To elucidate the role of RECK at the cell surface in modulating MT1-MMP,

pERK, and MMP-2 activation, I shed GPI-anchored proteins, which includes RECK,
from the surface using PI-PLC. PI-PLC treatment significantly increased MT1-MMP
protein levels (Fig. 4.7a) but did not alter pERK levels (Fig. 4.7b). PI-PLC treatment
caused an increase in the relative level of active MMP-2 (Fig. 4.7c). Secreted MMP-9
protein could not be detected. Of note - PI-PLC treatment did not alter the transcription of
a variety of genes (Fig. 4.8), nor did it alter the morphology, growth, or survival of these
cells.

4.3.5

Alteration in RECK Levels or PI-PLC Treatment had Varying
Effects on MMP-2, MMP-9, MT1-MMP, and TIMP-2 mRNA
Levels
Having shown that altered RECK levels had varying effects on protein levels of

MT1-MMP and pERK, I sought to better understand the mechanism of these changes by
examining changes in mRNA levels. Following RECK knockdown, qPCR analysis did
not reveal a significant change in the level of MMP-2, MMP-9, nor MT1-MMP mRNA.
There was, however, a significant decrease in TIMP-2 mRNA levels (Fig. 4.3).
Following RECK overexpression, PCR analysis revealed significant increases in
MT1-MMP and MMP-9 transcript levels, but no changes in MMP-2 nor TIMP-2
transcript levels (Fig. 4.8a). PI-PLC treatment of A6 cells did not alter the transcript
levels of MMP-2, MMP-9, MT1-MMP, nor TIMP-2 (Fig. 4.8b).
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Figure 4.6. Solubilization of RECK proteins following PI-PLC treatment.
24 hours following transfection of RECK constructs, control and transfected A6 cells
were treated with PI-PLC for 24 hours and cell lysates were collected and analyzed by
Western blot. (b) Densitometry quantification confirmed that the level of RECK proteins
bound to the cell was significantly reduced following PI-PLC treatment in both
mock-transfected and RECK-transfected cells. β-actin was used as a loading control.
Graphed data are based on 3 biological replicates (mean ± SD). Data are analyzed via
t-test; *, p≤0.05; **, p≤0.01.
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Figure 4.7 PI-PLC treatment caused an increase in MT1-MMP protein and MMP-2
activity levels.
(a) Densitometry quantification of MT1-MMP protein level normalized to β-actin in
control A6 cells treated with PI-PLC. MT1-MMP protein levels significantly increased in
PI-PLC-treated cells compared to untreated cells (set to 1). (b) Densitometry
quantification of pERK normalized to total ERK levels. pERK protein levels did not
significantly change following PI-PLC treatment. (c) Gelatin zymography was used to
measure protein levels of secreted pro-, intermediate, and active MMP-2 following
PI-PLC treatment in A6 cells. Data are presented as the ratio between active and total
(pro-, intermediate, and active) MMP-2 levels between untreated cells and
PI-PLC-treated cells. Active/total MMP-2 levels significantly increased in the media of
PI-PLC-treated cells compared to untreated cells (set to 1). Graphed data are based on 3
biological replicates (mean ± SD). Data are analyzed via t-test; ns, p>0.05; *, p≤0.05; **,
p≤0.01.

138

(a)
***

Control

PI-PLC
63 kDa

MT1-MMP

42 kDa

β-actin

MT1-MMP optical density
(A.U.)

3
2.5
2
1.5
1
0.5
0
perk june15 br3 cropped for ﬁgure

Control
PI-PLC
Control
-PLC Control
+PLC

totalerk br3 june15 cropped for ﬁgure

(b)

Control

PI-PLC

pERK

42 kDa

Total
ERK

42 kDa

pERK 1/2 / total ERK optical
density (A.U.)

1.5
ns
1

0.5

Location: /Users/jessicawillson/Desktop/24 hr PLC Treatment A6 Cells/Western Blot
Printed: 2018-06-26 11:48 AM

Location: /Users/jessicawillson/Desktop/24 hr PLC Treatment A6 Cells/Western Blot
0
Printed: 2018-06-26 11:46 AM

Control

Location: /Users/jessicawillson/Desktop/24 hr PLC Treatment A6 Cells/Western Blot
Printed: 2018-07-09 11:27 AM

Page 1 of 1

/Users/jessicawillson/Desktop/24 hr PLC Treatment A6 Cells/Western Blot/ChemiDoc Images 2018-06-20_14.01.13
Printed: 2018-07-09 11:30 AM
Page 1 of 1

PI-PLC
PLC

P

P

139

(c)
PI-PLC

Control

60 kDa

Pro-MMP-2
Int.MMP-2
Active MMP-2

Active MMP-2/total
MMP-2 (A.U.)

16

**

12

8

4

0
Control
PI-PLC
Control
-PLC Control
+PLC

140
Unlike MMP-2, MMP-9 transcript levels in A6 cells were extremely low (only
being detectable after 32 PCR cycles). Although MMP-9 transcript levels altered under
RECK manipulation (Fig. 4.8a), they never elevated enough to be detected using
zymography even when transcript levels increased.

4.4 Discussion
Adult epithelial cells, unlike their embryonic counterparts, move and invade only under
special situations, such as injury or disease. Past in vitro examination of MCF-7 epithelial
breast cancer cells, which are poorly invasive, has suggested that MT1-MMP orchestrates
this transition towards a more migratory phenotype (Cepeda et al., 2016; Walsh and
Damjanovski, 2011; Walsh et al., 2015). While the roles of ECM remodeling proteins
have gathered much interest due to their broad developmental and disease implications, it
has become clear that there isn’t a defined relationship between the level of a MMP and
the amount of ECM turnover (Cepeda et al., 2016). While not exhibiting overt abilities to
remodel the ECM or to become mesenchymal, non-migrating epithelial cells express low
levels of the enzymes and signaling molecules needed for these events. Indeed, A6 cells
have basal levels of MT1-MMP, MMP-2, RECK and pERK proteins (Fig. 4.1, 4.2). It is
this low and appropriately localized levels of MT1-MMP and TIMP-2 which can directly
regulate enzymatic activity, including the activation of proMMP-2 (Cepeda et al., 2017;
Itoh et al., 2001), as well as ERK cell signaling events (Cepeda et al., 2016; 2017) in
human epithelial cells. To address if the maintenance of low levels of MMPs is a
common mechanism seen in X. laevis epithelial cells, here I investigated the impact of
altered RECK levels in the context of the ECM remodelers MT1-MMP and MMP-2, as
well as pERK in X. laevis A6 cells.
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Figure 4.8 Effect of RECK overexpression and PI-PLC treatment on MMP-2,
MMP-9, MT1-MMP, and TIMP-2 mRNA levels.
The levels of MMP-2, MMP-9, MT1-MMP, and TIMP-2 mRNA were measured
following RECK overexpression and PI-PLC treatment in A6 cells using real-time qPCR.
(a) Following RECK overexpression, MMP-2 and TIMP-2 mRNA levels did not change
significantly, however, MMP-9 and MT1-MMP mRNA levels increased significantly
compared to control. (b) Treatment of cells with PI-PLC did not change MMP-2, MMP-9,
MT1-MMP, or TIMP-2 mRNA levels. Changes in gene expression were measured
relative to EF1α and normalized to control cells (set to 1). Results are based on 3
biological replicates (mean ± SEM; technical replicates, N=9). Data are analyzed via
t-test; *, p≤0.05; **, p≤0.01.
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The presence of MT1-MMP and active MMP-2 (measured by zymography)
demonstrated that A6 cells have at the least a basal ability to remodel the ECM. When
endogenous levels of RECK are reduced using MO treatment, no changes were seen in
MT1-MMP and pERK protein levels, nor MMP-2 activation (Fig. 4.2). Despite its ability
to act as an MMP inhibitor, reduced levels of RECK were not substantial enough to alter
MT1-MMP or MMP-2 levels, nor the basal level of ECM remodeling that may be
associated with them. However, this level of RECK knockdown was biologically relevant
as it was enough to decrease TIMP-2 mRNA levels significantly (Fig. 4.3). Thus, it
appears that A6 cells maintain low levels of RECK at the cell surface, levels which when
further reduced, do not impact the protein levels of MT1-MMP, MMP-2, or pERK.
As RECK knockdown did not alter MT1-MMP, pERK, nor MMP-2 activity
levels, I next examined the effect of RECK overexpression in A6 cells. RECK impedes
MT1-MMP activity by binding to its catalytic site and blocking its proteolysis, including
its ability to activate pro-MMP-2 (Dong et al., 2010). However, RECK overexpression
resulted in increased MT1-MMP mRNA and protein levels (Fig. 4.8a and 4.5a), and an
associated increase in MMP-2 activation (Fig. 4.5c). While A6 cells did not lower their
basal ECM remodeling abilities with respect to MT1-MMP and MMP-2 in response to
lowered RECK levels, increased RECK did trigger A6 cells to alter MMP levels. This
increase in MT1-MMP and MMP-2 levels could be a compensatory response with the
cells increasing these MMP levels to maintain a basal ability to remodel the ECM in
response to the increased levels of an inhibitor. Further, RECK is associated with
increased MT1-MMP endocytosis (Miki et al., 2007). Accordingly, increased RECK
levels may reduce cell-surface MT1-MMP protein levels, triggering the cells to increase
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MT1-MMP production. This RECK-mediated increase in MT1-MMP endocytosis rates
would also limit the ability of MT1-MMP to activate ERK, thus pERK levels would be
reduced under RECK overexpression conditions. In the presence of increased levels of an
MMP inhibitor, A6 cells attempt to maintain a basal level of ECM remodeling ability by
increasing MMP levels.
While A6 cells could tolerate the knockdown of RECK, as evident in their
maintained MT1-MMP and MMP-2 levels, I next sought to examine the necessity for
RECK to be membrane anchored. PI-PLC treatment was used to cleave RECK and other
GPI-linked proteins from the cell surface. PI-PLC treatment of A6 cells did not alter
transcript levels (Fig. 4.8b), nor did it alter the morphology, growth, or survival of these
cells. By these measures, PI-PLC treatment of A6 cells was not detrimental, while
immunoblot analysis did reveal a significant decrease in cell surface RECK levels
(Fig. 4.6).
Like RECK overexpression, PI-PLC treatment of A6 cells elevated both
MT1-MMP protein and MMP-2 activation levels (Fig. 4.7a,c). A possible mechanism
that may explain this is that while cell surface RECK may play a role in MT1-MMP
endocytosis (Miki et al., 2007), solubilized forms of RECK cannot. Following PI-PLC
treatment and RECK shedding, less MT1-MMP is internalized and recycled, with more
remaining at the cell surface. This increased level of MT1-MMP can then also facilitate
higher levels of MMP-2 activity. Indeed, the increase in MT1-MMP protein levels
(Fig. 4.7a) despite unaltered MT1-MMP mRNA changes (Fig. 4.8b) can be explained by
soluble RECK proteins not being able to recycle cell-surface MT1-MMP, independent of
transcriptional changes.
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Unlike RECK overexpression, which decreased pERK levels possibly due to
increased MT1-MMP recycling, PI-PLC treatment, which potentially reduced
MT1-MMP recycling, did not alter pERK protein levels in A6 cells (Fig. 4.7b). These
results suggest that cell surface localization of RECK proteins are important in
modulating MT1-MMP function.

4.5 Conclusions
X. laevis A6 cells express RECK, as well as pERK, MT1-MMP and MMP-2
levels that facilitate ECM remodeling activity as seen by zymography. RECK knockdown
did not alter MT1-MMP, pERK, nor MMP-2 activation and did not lower the ability of
the cell to remodel the ECM. Unlike RECK knockdown, RECK changes (overexpression
and cell surface shedding) that reduced the ability of the cell to remodel the ECM are
compensated for by increases in MT1-MMP and MMP-2 levels as the cell tries to
maintain a basal ability to remodel the ECM. A6 and other epithelial cells may attempt to
maintain basal abilities to remodel the ECM even when challenged by changes in MMP
inhibitor levels.
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5

General Discussion and Conclusions
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5.1 General Overview
5.1.1

Context and Significance of this Research
The ECM not only functions as a structural scaffold for tissues, but it also

contributes to the regulation of cell fate and behaviour. For proper ECM remodeling, a
delicate balance must exist between MMPs, which cleave components of the ECM, and
their inhibitors, TIMPs and RECK. Disruption of this balance leads to aberrant ECM
turnover, which is detrimental to the development and maintenance of multicellular
organisms. TIMPs were originally thought to be the main inhibitors of MMPs, however,
RECK also plays a crucial role in maintaining this delicate balance. RECK is a
lipid-anchored protein whose function has been established as an inhibitor of cell
migration in both development and disease models (reviewed in Willson et al., 2014).
Not only are MMPs and their inhibitors important for tissue remodeling, but it has
become increasingly evident that these proteins also play a critical role in cell fate by
modulating cell signaling events (Cepeda et al., 2017; Chirco et al., 2006;
Stetler-Stevenson, 2008; Walsh et al., 2015). Indeed, MMPs, TIMPs, and RECK are all
expressed during differentiation events in addition to regions where ECM remodeling and
large-scale cell movements are occurring (Nuttall et al., 2004). The interplay that exists
between MMPs, TIMPs, and RECK is thus made even more complex because of their
multifaceted roles. Although past studies have revealed an important role for RECK
during embryogenesis (Oh et al., 2001; Prendergast et al., 2012; Yamamoto et al., 2012),
the knowledge of the precise functions of RECK during this process is still limited. This
research is the first comprehensive examination of RECK during X. laevis development.
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5.1.2

Research Summary and General Conclusions
The overall goal of this research was to investigate the role of X. laevis RECK

during development and how it facilitates proper ECM remodeling and tissue patterning.
I used a combination of in vivo and in vitro experiments to accomplish this goal. Data
were organized into 3 chapters: Chapter 2: a) I analyzed the X. laevis RECK peptide
sequence with a variety of vertebrate and invertebrate RECK sequences to determine
evolutionary conservation of hallmark domains, and b) I knocked down RECK levels in
X. laevis embryos and assayed for morphological changes in development as well as
corresponding changes in developmental marker genes and ECM remodeling genes;
Chapter 3: I examined the localization patterns of RECK, MT1-MMP, and TIMP-2
proteins throughout early X. laevis development using IHC; Chapter 4: I used X. laevis
A6 cells to investigate how RECK regulates MT1-MMP, MMP-2, and pERK levels.
In general, I hypothesized that X. laevis RECK supports a role in regulating ECM
remodeling, as inhibition of MMP activity is a main function of RECK. Indeed, I was
able to demonstrate that RECK contributes to X. laevis development. Knockdown of
RECK expression in embryos resulted in neural tube closure failure as well as axial and
head defects (Fig. 2.5), suggesting uncontrolled ECM remodeling and impaired cell
migration. These phenotypes were attributed to global changes in MT1-MMP, MMP-2,
and TIMP-2 mRNA levels (Fig. 2.6). Moreover, I showed that X. laevis MT1-MMP and
TIMP-2 colocalized spatially in the neural tube and different regions of the head where
RECK was localized, particularly in the dorsal-ventral differentiation of the neural tube
(Fig. 3.1-3.4). Finally, I revealed that RECK modulated MT1-MMP protein levels in
X. laevis A6 cells, thereby affecting MMP-2 and ERK activation levels (Fig. 4.5, 4.7).
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Overall, my findings support the model that RECK is a unique regulator of ECM
remodeling and tissue patterning, whose absence leads to developmental defects due to
deregulation of MT1-MMP and MMP-2.

5.2 Contributions to the Current Knowledge of ECM Dynamics
5.2.1

Characterization of X. laevis RECK
When I began this research, only the mature X. laevis RECK sequence, lacking the

N- and C-terminal signaling domains, had been previously cloned by me. One of my first
tasks was to finish cloning the full-length coding sequence of X. laevis RECK (Fig. 2.1)
and perform a sequence analysis using a variety of vertebrate and invertebrate RECK
sequences to determine evolutionary conservation (Table 2.1). The first part of Chapter 2
revealed that all RECK sequences cloned to date, including X. laevis RECK, are highly
conserved at the amino acid level and share all the domains characteristic of RECK,
which was consistent with my original hypothesis.
RECK proteins are rich in cysteine residues (9%) and contain 5 repeats of a
putative cysteine knot motif located near their N-terminus (Table 2.1). The number and
placement of these cysteines are highly conserved among both vertebrates and
invertebrates. Based on a current NCBI Homologene search of RECK, there are
9 vertebrates: 7 mammalian, as well as chicken and frog, that have been characterized to
date. Among these 9 vertebrate RECK peptide sequences, there is 100% conservation of
cysteines in each cysteine knot motif. Within the cysteine knot motifs are potential
glycosylation sites at 5 asparagine residues that have been identified to contribute to
RECK’s role as an MMP inhibitor (Simizu et al., 2005).
Of the 3 Kazal motifs, which have been identified as MMP inhibitory domains
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(Chang et al., 2008), only the 1st domain completely matches the defined consensus Kazal
motif sequence (X8CX6CX7CX10CX2CX17C), whereas the other 2 domains only contain
partial Kazal motif identities (Takahashi et al., 1998). The 1st Kazal motif shares 87%
identity in mammals and shares 100% conservation of cysteines in vertebrates. Even the
2 partial Kazal motifs are very well conserved and contain conserved cysteine residues as
well as the same number of amino acids between the cysteine residues in vertebrates. The
high conservation of these 2 partial Kazal motifs suggests that they may also contribute to
protease inhibition. Indeed, evidence does show that these Kazal motifs play a role in
MMP inhibition (Chang et al., 2008).
The middle portion of RECK proteins also contains 2 partial EGF-like repeats.
EGF

domains

are

evolutionary

conserved

regions

found

in

a

variety

of

membrane-anchored and secreted proteins. Proteins that contain EGF-domains may have
the potential to bind to EGF receptors and stimulate cell proliferation, survival, and
differentiation (Wouters et al., 2005). The high conservation of these 2 domains among
vertebrate RECK sequences suggests that these domains contribute to a cell signaling
function that is independent of RECK’s MMP inhibitory role, as recent evidence has
shown that RECK can trigger such pathways autonomously of MMPs (Walsh et al.,
2015).
These characterized domains of RECK, although highly conserved, only make up
a small portion of the RECK coding sequence. There are other highly conserved, but
uncharacterized, regions within RECK that may also represent important functional
domains. For example, during sequence analysis of RECK in Chapter 2, following the
last cysteine knot motif, I identified a 32 amino acid region, which I termed LAD-RSC
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(Fig. 2.1), that is the most conserved region of RECK (91% conserved in mammals and
88% conserved in vertebrates) (Table 2.1). This sequence motif has not previously been
reported nor does it have any known homology to other proteins, however, given its
extremely high conservation, this suggests that the LAD-RSC domain may have global
implications to RECK function.
It is interesting to note that RECK sequences are almost 3,000 bp, and throughout
evolution, there has never been a duplication or omission of any of the characterized
domains, nor of the gene itself. Even in the X. laevis genome, which is allotetraploid,
meaning that it may contain duplicates for some genes, I only found a single copy of the
RECK gene. This was also seen in the zebrafish genome, which is also tetraploid. Kumari
et al. (2018) only identified a single copy of the RECK gene. On the other hand, there are
4 mammalian TIMPs that appear to be a result of gene duplication, since only 1 TIMP
gene is found in insects, and not all orthologues are present in all vertebrates (Brew and
Nagase, 2010). MMPs first appeared as basic proteins with a catalytic domain, but
through gene duplication, fusion, and exon shuffling, acquired the additional domains and
functional diversity currently exhibited by the various members of the MMP family
(Fanjul-Fernández et al., 2010). But the RECK gene is the only one of its kind and shares
high peptide sequence conservation among vertebrates. This strongly implicates that all
vertebrate RECK proteins share a similar biological function.

5.2.2

RECK is a Key Regulator During X. laevis Development
It has been well-known for a long time that there needs to be a proper balance

between MMPs and their inhibitors in order to facilitate controlled ECM remodeling
during development. Numerous studies have already shown that disturbing this balance,
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either by disrupting MMP or TIMP levels, results in a wide array of developmental
defects (Lambert et al., 2004; Vu and Werb, 2000). However, unlike MMPs and TIMPs,
in which the gene knockout embryos are still viable, most likely due to functional
redundancy, there is only one RECK gene, and knockout of this gene in mice results in
embryonic lethality (Oh et al., 2001). Therefore, RECK must play an essential role during
development, although the exact mechanisms remain unclear. The second part of Chapter
2 explored the consequences of knocking down RECK expression in X. laevis embryos.
My data revealed for the first time that RECK contributes to tissue patterning during X.
laevis development.
RECK knockdown in 1-cell stage embryos led to severe developmental defects in
neural tube closure, an event that relies on large-scale cell movements and extensive
ECM remodeling. This was consistent with my original hypothesis, which stated that
knockdown in RECK levels would cause neural tube defects in X. laevis embryos.
Changes in chordin mRNA levels in RECK knockdown embryos coincided with this
phenotype, as chordin plays an important role in inducing neural structures (Sasai et al.,
1994). When comparing data from Chapters 2 and 3, I observed that the sites of
prominent defects in RECK knockdown embryos (the neural tube and head; Fig. 2.5)
coincided with sites of abundant RECK expression in wildtype embryos (Fig. 3.1, 3.2).
Also of note was the trending increase that occurred in the mRNA levels of FoxD3, a
neural crest cell marker, in RECK knockdown embryos (Fig. 2.6). Indeed, in Chapters 2
and 3, I revealed that RECK proteins are localized to regions where neural crest cells
reside: on the dorsal side of the neural tube prior to migration (the neural crest) and in the
branchial arches, a structure in the head region where neural crest cells eventually
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migrate (Fig. 2.2, 3.1, 3.2). Given that past studies have already indicated an important
role for RECK in the migration of neural crest cells (Prendergast et al., 2012), my results
suggest that the axial and head defects that were seen in RECK knockdown embryos
(Fig. 2.5) may have resulted from aberrant neural crest cell migration. In fact, the reduced
head structures that were seen in RECK knockdown embryos is similar to the phenotypes
observed in zebrafish when neural crest cell migration is disrupted (Tobin et al., 2008).
Because RECK knockdown caused global changes in MT1-MMP and TIMP-2
mRNA levels, along with RECK, I also investigated the spatial expression patterns of
these 2 proteins during X. laevis development. The sites of RECK localization coincided
with overlapping expression patterns of MT1-MMP and TIMP-2, especially in the D-V
differentiation of the neural tube (as summarized in Fig. 5.1). This was consistent with
my hypothesis, which stated that X. laevis RECK would colocalize with MT1-MMP in
dorsal axial structures, including the neural tube and head region. Given that past in vitro
studies have shown that RECK interacts with MT1-MMP on the cell surface (Oh et al.,
2001; Matsuzaki et al., 2018; Miki et al., 2007), it was not surprising that both proteins
displayed highly similar expression patterns throughout early X. laevis development.
What was intriguing, however, was that TIMP-2 also displayed a very similar expression
pattern to RECK, although there is no evidence to suggest they interact with one another
on the cell surface. But seeing as how MT1-MMP also shares the same expression pattern
as TIMP-2, and there is evidence in vitro to show that TIMP-2 complexes with
MT1-MMP (Itoh et al., 2001), it is more likely that TIMP-2 and RECK both interact with
MT1-MMP and influence its behaviour during development, such as the ability of
MT1-MMP to activate MMP-2 (Itoh et al., 2001), or the ability of MT1-MMP to induce
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Figure 5.1 Schematic representation of overlapping RECK, MT1-MMP, and
TIMP-2 proteins in the D-V differentiation of the neural tube during X. laevis
development.
Schematic representation of transverse sections of stage 20, 28, and 34 X. laevis embryos.
Red indicates overlapping expression patterns of RECK, MT1-MMP, and TIMP-2
proteins in the D-V differentiation of the neural tube at stages 20, 28, and 34.
Abbreviations: E=endoderm; Ep=epidermis; NT=neural tube; S=somites.
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cell signaling cascades (ie. ERK signaling) (Cepeda et al., 2017; Takino et al., 2010).
My global analysis in Chapter 2 showed that RECK knockdown altered
MT1-MMP, MMP-2, and TIMP-2 mRNA levels (Fig. 2.6). Furthermore, in Chapter 3, I
showed that RECK and MT1-MMP displayed highly similar expression patterns
throughout early X. laevis development (Fig. 3.1-3.4), which is suggestive that they
interact with one another during development. However, RECK’s interaction with
molecules and specific cellular pathways are difficult to detect in multicellular embryos.
Therefore, in Chapter 4, I analyzed the role of RECK on ECM dynamics in a
well-established X. laevis cell line, kidney epithelial A6 cells. A6 cells act as typical
epithelial cells and express many ECM regulatory genes, including RECK, MT1-MMP,
MMP-2, and TIMP-2. MT1-MMP’s regulation of pro-MMP-2 and ERK activation
position it as a key indicator of the cell’s ability to remodel the ECM and migrate. Thus,
given that MT1-MMP and MMP-2 can be pivotal to ECM remodeling during
development, I investigated how modulation of RECK levels would impact both of these
MMPs in vitro.
Although RECK knockdown did not alter MT1-MMP levels nor MMP-2 activity,
RECK overexpression and PI-PLC treatment both increased ECM remodeling potential
through increased MT1-MMP protein and relative MMP-2 activation levels. These
results were contrary to my hypothesis, which stated that knockdown/shedding of RECK
in X. laevis A6 cells would result in increased MT1-MMP and MMP-2 levels, whereas
overexpression of RECK would result in reduced MT1-MMP and MMP-2 levels. Instead,
I observed a compensatory feedback response, in which changes in RECK levels that
reduced the ability of the cell to remodel the ECM (overexpression and cell surface
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shedding) were compensated for by cellular increases in MT1-MMP levels and MMP-2
levels as seen by zymography. Taken together, my results are highly suggestive that
RECK is a key regulator of MT1-MMP in X. laevis (as summarized in Fig. 5.2).
Although RECK is well established as a suppressor of cell migration due to its
ability to inhibit MMPs, more recent studies have shed light on MMP-independent
functions of RECK, particularly during cell fate and differentiation events. Most recently,
Vallon et al. (2018) revealed that RECK is a receptor to the ligand Wnt7 in rat brain
blood vessels and mediates canonical Wnt/ß-catenin signaling in endothelial cells by
stabilizing active Wnt7 ligands. Interestingly, when I examined the localization pattern of
RECK in Chapter 3, I saw that RECK, along with MT1-MMP and TIMP-2, localized in
the D-V differentiation of the neural tube (Fig. 5.1). This patterning event relies on
coordinated cell signaling events rather than ECM turnover events. Therefore, these
results suggest a role for these proteins during patterning events that are independent
from their roles as regulators of ECM remodeling. In fact, RECK has already been
implicated to be an important player during neurogenesis in mice (Muraguchi et al.,
2007; Park et al., 2013).
It is well known that a complex interplay exists between RECK, MMPs, and
TIMPs, interactions that need to be examined to truly understand the role of RECK in
ECM remodeling during development. Overall, my results support the view that MMP
regulation is critical to ensure proper ECM remodeling during development. Furthermore,
my results suggest that RECK is a key modulator of MT1-MMP in X. laevis.

5.3 Limitations of this Research and Future Studies
As my research was the first to characterize RECK function during X. laevis
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Figure 5.2 Model of RECK modulation of MT1-MMP in X. laevis.
(a) Cell surface RECK interacts with MT1-MMP and promotes its internalization in
X. laevis A6 cells. As a compensatory feedback response, A6 cells upregulate MT1-MMP
expression to increase MT1-MMP protein levels on the cell surface. (b) Solubilized
RECK (cleaved by PI-PLC) binds to and inhibits MT1-MMP activity but cannot promote
MT1-MMP internalization. As a result, MT1-MMP protein levels (but not mRNA levels)
increase in A6 cells.
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development, I focused on global changes within the whole embryo. Consequently, I was
only able to detect large-scale changes in ECM remodeling genes and developmental
marker genes (Fig. 2.6) rather than tissue-specific changes. However, since proper ECM
remodeling is critical for large-scale cell movements during development, it is quite
likely that many tissues besides the neural tube were affected by RECK knockdown.
Therefore, a more comprehensive analysis of the morphological defects that resulted
from reduced RECK levels in X. laevis embryos is warranted. This should be
accomplished through in situ analysis of developmental marker genes in RECK
knockdown embryos versus wildtype. For example, analysis of crestin, a marker for
migratory neural crest cells (Rubinstein et al., 2000), in RECK knockdown embryos
would be of great interest given the fact that my results strongly suggest that neural crest
cell migration was affected in these embryos.
To attenuate the effects of RECK knockdown, future studies should co-inject
MT1-MMP MOs in X. laevis embryos, as they are known to be inhibited by RECK. If the
phenotype is rescued, this would imply that RECK is a key regulator of MT1-MMP in
X. laevis. Finally, examination of changes in additional signaling markers, besides pERK,
such as Notch, VEGF, or Wnt7a signaling, using Western blotting, may help link the
non-MMP-inhibitory role of RECK.
Although my IHC analysis confirmed that RECK colocalizes with MT1-MMP
and TIMP-2 in the neural tube (Fig. 5.1), I did not investigate the specific cell surface
binding partners of RECK during X. laevis development. However, my last chapter does
suggest that RECK modulates MT1-MMP protein levels in X. laevis. To build on these
results, immunocytochemistry experiments using fluorescently-labeled MT1-MMP
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antibodies would be useful to confirm that RECK modulates MT1-MMP internalization
in A6 cells. Co-immunoprecipitation experiments could also be useful in determining
potential cell surface binding partners for RECK in X. laevis A6 cells, such as Wnt7,
EGF, and Notch ligands (Muraguchi et al., 2007; Vallon et al., 2018). RECK is a large
protein with a number of highly conserved domains, the functions of most of which are
currently unknown. Therefore, future work should involve site-specific mutations to
disrupt the function of different domains, especially the highly conserved LAD-RSC
domain, to determine if they contribute to the overall function of the protein, as was
previously done with the glycosylation sites (Simizu et al., 2005). This may help further
elucidate the potential non-MMP inhibitory roles of RECK.

5.4 Conclusions
ECM dynamics are very complex, in part due to differing ECM compositions as
well as differing expression patterns of MMP and TIMPs/RECK in each tissue. RECK is
a recently described player in mediating MMPs. Its large size and high evolutionary
conservation suggest it plays an important role in vertebrates. This study is the first to
characterize X. laevis RECK during early development. My results indicate that
inappropriate expression of RECK interferes with embryogenesis and causes aberrant
expression of MT1-MMP and MMP-2, both of which play a major role in cell migration.
The colocalization patterns of RECK and MT1-MMP during neural tube differentiation
in X. laevis as well as my demonstration in vitro that RECK modulates MT1-MMP and
MMP-2 protein levels suggest that RECK and MT1-MMP function together during
development to ensure proper ECM remodeling and cell signaling. Overall, this study not
only supports the role for RECK as a modulator of ECM remodeling during development

165
but also sheds light on the importance of this protein during patterning and differentiation
events.

166

5.5 References
Brew, K., Nagase, H. (2010). The tissue inhibitors of metalloproteinases (TIMPs): An
ancient family with structural and functional diversity. Biochim Biophys Acta. 1803: 5571.
Cepeda, M.A., Evered, C.L., Pelling, J.H., Damjanovski, S. (2017). Inhibition of
MT1-MMP proteolytic function and ERK1/2 signalling influences cell migration and
invasion through changes in MMP-2 and MMP-9 levels. J Cell Commun Signal. 11: 167179.
Chang, C.K., Hung, W.C., Chang, H.C. (2008). The Kazal motifs of RECK protein
inhibit MMP- 9 secretion and activity and reduce metastasis of lung cancer cells in vitro
and in vivo. J Cell Mol. Med. 12: 2781-2789.
Chirco, R., Liu, X.W., Jung, K.K., Kim, H.R. (2006). Novel functions of TIMPs in cell
signaling. Cancer Metastasis Rev. 25: 99-113.
Fanjul-Fernández, M., Folgueras, A.R., Cabrera, S., López-Otín, C. (2010). Matrix
metalloproteinases: evolution, gene regulation and functional analysis in mouse models.
Biochim Biophys Acta. 1803: 3-19.
Itoh, Y., Takamura, A., Ito, N., Maru, Y., Sato, H., Suenaga, N., Aoki, T., Seiki, M.
(2001). Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation
on the cell surface and promotes tumor cell invasion. EMBO J. 20: 4782-4793.
Kumari, R., Silic, M.R., Jones-Hall, Y.L., Nin-Velez, A., Yang, J.Y., Mittal, S.K., Zhang,
G. (2018). Identification of RECK as an evolutionarily conserved tumor suppressor gene
for zebrafish malignant peripheral nerve sheath tumors. Oncotarget. 9: 23494-23504.
Lambert, E., Dassé, E., Haye, B., Petitfrére, E. (2004). TIMPs as multifacial proteins. Crit
Rev Oncol Hematol. 49: 187-189.
Matsuzaki, T., Kitayama, H., Omura, A., Nishimoto, E., Alexander, D.B., Noda, M.
(2018). The RECK tumor-suppressor protein binds and stabilizes ADAMTS10. Biol
Open. 7: bio033985.
Miki, T., Takegami, Y., Okawa, K., Muraguchi, T., Noda, M., Takahashi, C. (2007). The
reversion-inducing cysteine-rich protein with Kazal motifs (RECK) interacts with
membrane type 1 matrix metalloproteinase and CD13/aminopeptidase N and modulates
their endocytic pathways. J Biol Chem. 282: 12341-12352.
Muraguchi, T., Takegami, Y., Ohtsuka, T., Kitajima, S., Chandana, E.P., Omura, A.,
Miki, T., Takahashi, R., Matsumoto, N., Ludwig, A., Noda, M., Takahashi, C. (2007).
Reck modulates Notch signaling during cortical neurogenesis by regulating ADAM10
activity. Nat Neurosci. 10: 838-845.

167
Nuttall, R.K., Sampieri, C.L., Pennington, C.J., Gill, S.E., Schultz, G.A., Edwards, D.R.
(2004). Expression analysis of the entire MMP and TIMP gene families during mouse
tissue development. FEBS Letters. 563: 129-134.
Oh, J., Takahashi, R., Kondo, S., Mizoguchi, A., Nishimura, S., Imamura, Y., Kitayama,
H., Alexander, D.B., Horan, T.P., Arakawa, T., Yoshida, H., Nishikawa, S., Itoh, Y.,
Seiki, M., Itohara, S., Takahashi, C., Noda, M. (2001). The membrane-anchored MMP
inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell.
107: 789-800.
Park, S., Lee, C., Sabharwal, P., Zhang, M., Meyers, C.L., Sockanathan, S. (2013). GDE2
promotes neurogenesis by glycosylphosphatidylinositol-anchor cleavage of RECK.
Science. 339: 324-328.
Prendergast, A., Linbo, T.H., Swarts, T., Ungos, J.M., McGraw, H.F., Krispin, S.,
Weinstein, B.M., Raible, D.W. (2012). The metalloproteinase inhibitor RECK is essential
for zebrafish DRG development. Development. 139: 1141-1152.
Rubinstein, A.L., Lee, D., Luo, R., Henion, P.D., Halpern, M.E. (2000). Genes dependent
on zebrafish cyclops function identified by AFLP differential gene expression screen.
Genesis. 26: 86-97.
Sasai, Y., Lu, B., Steinbeisser, H., Geissert, D., Gont, L.K., De Robertis, E.M. (1994).
Xenopus chordin: a novel dorsalizing factor activated by organizer-specific homeobox
genes. Cell. 79: 779:790.
Simizu, S., Takagi, S., Tamura, Y., Osada, H. (2005). RECK-mediated suppression of
tumor cell invasion is regulated by glycosylation in human tumor cell lines. Cancer Res.
65: 7455-7461.
Stetler-Stevenson, W.G. (2008). Tissue inhibitors of metalloproteinases in cell signaling:
metalloproteinase-independent biological activities. Sci Signal. 1: 1-19.
Takahashi, C., Sheng, Z., Horan, T.P., Kitayama, H., Maki, M., Hitomi, K., Kitaura, Y.,
Takai, S., Sasahara, R.M., Horimoto, A., Ikawa, Y., Ratzkin, B.J., Arakawa, T., Noda, M.
(1998). Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the
membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA. 95: 13221-13226.
Takino, T., Tsuge, H., Ozawa, T., Sato, H. (2010). MT1-MMP promotes cell growth and
ERK activation through c-Src and paxillin in three-dimensional collagen matrix.
Biochem Biophys Res Commun. 396: 1042-1047.

168
Tobin, J.L., Di Franco, M., Eichers, E., May-Simera, H., Garcia, M., Yan, J., Quinian, R.,
Justice, M.J., Hennekam, R.C., Briscoe, J., Tada, M., Mayor, R., Burns, A.J., Lupski,
J.R., Hammond, P., Beales, P.L. (2008). Inhibition of neural crest migration underlies
craniofacial dysmorphology and Hirschsprung’s disease in Bardet-Biedl syndrome. Proc
Natl Acad Sci USA. 105: 6714-6719.
Vallon, M., Yuki, K., Nguyen, T.D., Chang, J., Yuan, J., Siepe, D. (2018). A
RECK-WNT7 Receptor-Ligand Interaction Enables Isoform-Specific Regulation of Wnt
Bioavailability. Cell Rep. 25: 339-349.
Vu, T.H., Werb, Z. (2000). Matrix metalloproteinases: effectors of development and
normal physiology. Genes Dev. 14: 2123-2133.
Walsh, L.A., Roy, D.M., Reyngold, M., Giri, D., Snyder, A., Turcan, S., Badwe, C.R.,
Lyman, J., Bromberg, J., King, T.A., Chan, T.A. (2015). RECK controls breast cancer
metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch.
Oncogene. 34: 2189-2203.
Willson, J.A., Damjanovski, S. (2014). Vertebrate RECK in development and disease.
Trends Cell Mol Biol. 9: 95-105.
Wouters, M.A., Rigoutsos, I., Chu, C.K., Feng, L.L., Sparrow, D.B., Dunwoodie, S.L.
(2005). Evolution of distinct EGF domains with specific functions. Protein Sci. 14: 10911103.
Yamamoto, M., Matsuzaki, T., Takahashi, R., Adachi, E., Maeda, Y., Yamaguchi, S.,
Kitayama, H., Echizenya, M., Morioka, Y., Alexander, D.B., Yagi, T., Itohara, S.,
Nakamura, T., Akiyama, H., Noda, M. (2012). The transformation suppressor gene Reck
is required for postaxial patterning in mouse forelimbs. Biol Open. 1: 458-466.

169

Appendices
Mail - Jessica Willson - Outlook

https://outlook.office.com/mail/deeplink?version=2019070701...

Appendix A Copyright Permission
" Reply all

!

# Delete

$ Junk

Block

%

Research Trends: RT/CMB/81
RT

Research Trends <rtrends@researchtrends.ne
t>

&

'

"

(

%

Mon 7/15/2019 2:32 AM
Jessica Willson )

15 July 2019
Dear Jessica Willson,
Thanks for the mail. We hereby grant you permission to
re-use material from the below stated article published in
our journal ‘Trends in Cell & Molecular Biology’, in your
Ph.D thesis.
‘Jessica A. Willson and Sashko Damjanovski, 2014, Vertebrate
RECK in development and disease, Trends in Cell & Molecular
Biology, Vol. 9, 95 – 105’.
This permission is subject to the usual requirement of
acknowledgment being made to our journal within the text as
the source of original publication. The acknowledgement may
please be cited along the following lines by clearly stating
the source:
Reproduced from, ‘Jessica A. Willson and Sashko Damjanovski,
2014, Vertebrate RECK in development and disease, Trends in
Cell & Molecular Biology, Vol. 9, 95 – 105’.
If any part of the material to be used has appeared in our
publication with credit or acknowledgement to another
source, permission must also be sought from that source. If
such permission is not obtained then that material may not
be included in your publication.
At this point, we would like to wish you all the best with
your thesis work.
Sivaprasad S.
Research Trends (P) Ltd.
------------------------------ Your message of 14 July 2019 -----1 of 1

2019-07-15, 10:32 a.m.

170
Appendix B X. laevis RECK full-length coding sequence
(Accession Number: KM225791.1)
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Appendix C Amino acid sequences of the 3 Kazal motifs among different species

Fig. C.1. Clustal Omega alignment of the 3 Kazal motif domains of select animals.
Amino acid sequences of the 3 Kazal motif domains among different species. Conserved
cysteine residues are highlighted in red and conserved tyrosine residues are highlighted in
blue.
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Appendix D The developmental phenotypes of X. laevis embryos

Number (%) of embryos at specified phenotype 1 day
post fertilization
Normal

Moderate

Total
number of
embryos

Severe

RECK
MO

0

83 (59%)

57 (41%)

140

Control

138 (91%)

14 (9%)

0

152

Fig. D.1. The developmental phenotypes of X. laevis embryos following RECK
Morpholino injection into one-cell stage fertilized embryos.
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Appendix E Zymography for BB94 treatment
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Int. MMP-2
Active MMP-2
Pro-MMP-2
Int. MMP-2
Active MMP-2

Fig. E.1. Zymography for BB94 treatment.
Gelatin zymography was used to measure protein levels of secreted pro-, intermediate,
and active MMP-2 following 10 µM BB94 treatment in A6 cells compared to untreated
cells.
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Appendix F Zymography for MMP-9 detection

Pro-MMP-2
Int. MMP-2
Active MMP-2
Pro-MMP-2
Int. MMP-2
Active MMP-2

Fig. F.1. Zymography for MMP-9 detection.
Gelatin zymography was used to measure the protein levels of MMP-2 and MMP-9 in A6
cells. MMP-9 protein could not be detected in the media of A6 cells at the expected size
of 84 kDa.
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